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Chapter 1
Introduction
In the last years, cancer has become a more and more frequent disease with
approximately 3.2 million incidences per year just in Europe [23]. However,
there are huge diﬀerences in the characteristics of individual cancer tumors,
which lead to a diﬀerent assessment of their aggressiveness. Here, we focus
on breast cancer tumors, one of the most common kinds of tumors [44], and
the question of whether a breast cancer patient might benefit from adjuvant
therapy such as chemotherapy. For clinical diagnosis, criteria such as tumor size,
histological grade and age (of the patient) are used to decide whether adjuvant
therapy will be applied [20, 27]. However, this method causes overtreatment of
many patients that are not in need for this therapy [10, 59, 60].
Cancer cells forming a tumor are characterized by their uncontrolled growth
compared to normal tissue. Since this is caused by gene abnormalities, accessing
the genetic code of these cells can reveal valuable information about the special
characteristics of an individual tumor. This is done by measuring the amount of
messenger RNA that enables gene expression, i.e., the process of transforming
DNA code into proteins, defining the actual behavior of the cell.
For many years, measuring the expression of genes was elaborate and time
consuming, until the development of microarray technology in the 1990s, which
allows for the eﬃcient extraction of thousands of gene expressions at a time
[30]. Therefore, it has been possible to record large data sets suitable for disease
classification on the basis of statistical analysis and machine learning techniques.
One of the first commercially available tests for tumor outcome prediction
that takes advantage of the microarray technology is the MammaPrint test that
has been developed in 2002 by van’t Veer et al [60]. It allows for the prediction
of distant metastasis development of breast cancer tumors by classifying their
gene expression data. The test was developed analyzing tumor tissue from 78
breast cancer patients younger than 55 years for which it was known whether
they developed distant metastases within 5 years after diagnosis. The advantage
of MammaPrint compared to clinical characteristics defined in the NIH [27] and
St. Gallen [20] guidelines is, that it produces a much lower rate of type II
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errors1 while keeping the type I errors2 comparably low (< 10%). This is a
huge improvement because using the test can therefore save a lot of people
from unnecessary chemotherapy that is meant to reduce the risk of metastasis
development [60].
Generally, since microarrays became available for the extraction of gene data
there has been a vast amount of research studies concerning disease classification
based on microarray gene expression data (see e.g., [39, 52]). Topics that are
addressed in these studies mainly concern the selection of genes that are able
to distinguish between diﬀerent classes (feature selection) and the definition of
appropriate classification algorithms as well as their validation.
Especially the problem of feature selection deserves particular attention:
Although a lot of studies defining classifiers for the prediction of breast cancer
outcome have been published, the overlap of the selected features within these
studies is remarkably low, even though performances are comparable [21]. This
might lead to the conclusion that there is not just one unique set of optimal
features, but rather a lot of non-overlapping feature sets with approximately
the same predication power that cover similar biological functionalities involved
in disease progression. On the other hand, taking into account the low number
of samples in theses studies (∼ 100) compared to the huge number of variables
(genes) (∼ 25,000), feature selection might be strongly dependent on the given
set of training samples [41].
For this study we have access to a total of about 1000 samples (see Appendix
C) for the analysis of classification and feature selection methods. All samples
are taken from breast cancer patients, who depending on the data (sub-)set
are lymph node negative or have a maximum of three lymph nodes that are
positive, i.e., metastatic cells are found in maximal three lymph nodes adjacent
to the primary tumor. The classification task is to predict the development of
distant metastases on the basis of gene expression profiles obtained by microar-
ray measurements. A distant metastasis or metastatic disease is the spread of
cancer cells from the primary tumor to distant lymph nodes or other organs of
the body [42]. In contrast to that, the spread to regional lymph nodes is called
lymph node involvement or regional disease.
As the basis of our analysis we take the MammaPrint algorithm, which
classifies tumor samples based on a set of 70 genes. We will first concentrate on
classification using these genes rather than considering the whole genome. For
comparing the quality of classification results we will – similar to the developers
of MammaPrint – focus on restricting the maximal number of type II errors
(false prediction of remaining metastasis free) and only if this is provided regard
the minimization of type I errors. This defines a special kind of classification
problem which leads to a strong focus on nearest centroid classifiers (such as
MammaPrint) that allow for an easy incorporation of this restriction in the
classification assignment (see chapter 4). After determining the classifier that
1Falsely predicting distant metastasis development (for patients that remain free of distant
metastasis for at least 5 years).
2Falsely predicting that no distant metastasis will develop within 5 years.
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performed best on our test data (using the set of 70 genes as features), we will
then turn to analyzing the influence of diﬀerent feature selection methods on its
performance (see chapter 5). Ideally, we would want to compare each of these
feature selection methods in conjunction with each of the classifiers, but in the
interest of eﬃciency we decided to compare feature selection methods using the
previously best performing classifier only.
In chapter 2 we describe the methods of data extraction, data preprocessing
and classification analysis used within this study. Next, we give an overview
of commonly used classification and feature selection methods in the area of
the analysis of microarray gene expression data (chapter 3). In this chapter we
will also discuss why the nearest centroid method is particularly suitable for
the special classification problem considered here. This motivates the detailed
analysis and comparison of diﬀerent nearest centroid classifiers in chapter 4.
Thereafter, we will study the influence of various feature selection methods
on the performance of nearest centroid classification (chapter 5). Finally, in
chapter 6, we conclude the results obtained in chapters 4 and 5 and discuss
possible future work.
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Chapter 2
Methods
DNA microarray technology allows for a fast analysis of thousands of genes in
parallel. Data collected by this technique is the basis for many classification
methods developed in the area of predicting disease outcome [32, 39, 52]. Fil-
tering the large amount of data and defining a meaningful classifier to obtain a
reliable prediction of the outcome is the main goal of microarray gene expression
classification.
In this study we will consider the problem setting of predicting distant tumor
metastases development based on gene expression levels measured on microar-
rays. Before looking at the classification problem itself, we first explain how data
can be extracted from microarrays (section 2.1) and what preprocessing steps
are conducted (section 2.2). Then we turn to the definition of the specific clas-
sification task and error measures that are used throughout the study (section
2.3). In section 2.4 we finally introduce methods for the evaluation of classifi-
cation performance that are necessary for the optimization and comparison of
classifiers presented in chapters 4 and 5.
2.1 Measuring Gene Expressions Using Microar-
ray Technology
DNA microarrays are a powerful tool to measure expressions of almost all hu-
man genes very fast and on very limited space [32, 39, 52]. A microarray consists
of a large variety of spots each of them being less than 250µm in diameter and
capable of binding a specific DNA molecule. There are various microarray plat-
forms [30] which we do not explain in detail here, but concentrate on those that
use complementary-RNA (cRNA) as input probes, such as the Hu25K, 44K,
HD44K and LD8pack arrays (by Agilent Technologies [1]), that are used for
obtaining the data considered in this study. Whereas the first microarray com-
prises the whole human genome, the others are user-specified arrays that are
designed to measure a set of 231 predefined genes more accurately since these
are measured multiple times on one array. The Hu25K microarray containing
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25,000 60-polymer oligonucleotide probes has been used during the develop-
ment of the MammaPrint algorithm in [60]. Afterwards, for the diagnostic use
of MammaPrint, it has been replaced by the low-density 8pack (LD8pack) ar-
ray, that measures less genes, i.e. contains only 1,900 probes, where each of
the 231 genes of interest is measured three times [26]. Furthermore on just one
array slide, there are eight identical sub-arrays allowing for eight simultaneous
analyses. More recently the Agilent 44K and HD44K arrays have been devel-
oped which measure more than 41,000 probes, where for the HD44K array four
identical 44K sub-arrays are present on one slide. In these (sub-)arrays each of
the 231 genes is measured five times.
For this study we had access to multiple datasets, each of them being mea-
sured on one of the aforementioned microarrays. An overview of all datasets
and the corresponding microarrays used can be found in Appendix C.
In the human body, DNA is transcribed to the so called messenger-RNA
(mRNA), which then translates into amino acid sequences forming a particular
protein. This process is called gene expression. Measuring gene expressions
gives valuable insights into the genetic code of cells and in particular cancer
cells and can therefore be used to reveal information about cancer behavior
such as developing metastases. Microarray technology is capable of measuring
thousands of gene expressions simultaneously which is why it gained so much
attention in the area of cancer classification.
For microarray analysis mRNA is isolated from a tissue sample containing
cancer cells. The extracted mRNA is amplified (replicated multiple times) and
labeled with fluorescent markers (dyes) to obtain labeled cRNA.1 Because of the
nature of DNA, which usually is connected to its complementary part in a double
helix, the labeled cRNA can be bound to small parts of DNA which are attached
to the microarray. This process is called hybridization. For comparison, a second
batch of cRNA is built from mRNA of a so called reference pool, which in our
case consists of an equal amount of RNA from various breast cancer tumors.
The two batches are labeled diﬀerently using diﬀerent dyes, red-fluorescent Cy5
and green-fluorescent Cy3, and thereafter hybridized on the same microarray.
A scanner is used to measure the amount of fluorescent dyes on each spot via
imaging the microarray slide. It locates the spots and calculates the fluorescence
intensities (Int(Cy3) and Int(Cy5)) for all pixels within each spot and outside
of the spot (in the so called background). The gene expression level of each gene
expr(g) is given by the log10 ratio2 of the fluorescent dye intensities:
expr(g) = log10
￿
Int(Cy5)
Int(Cy3)
￿
(2.1)
which is calculated after preprocessing via subtracting background noise and
normalization of the intensities with respect to so called housekeeping genes or
normalization genes.
1See [59, 60] for more information on RNA isolation and labeling.
2Other common choices are log2 or the natural logarithm ln.
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2.2 Data Preprocessing
The measurement of gene expressions with microarrays underlies a variety of
sources for errors and variability, e.g., due to changing experimental conditions.
Therefore, various preprocessing steps have to be implemented before a final
gene expression measure is obtained.
Given the scanned image of the fluorescent intensities, feature extraction
tools such as the one provided by Agilent Technologies [2], first search for the
actual spots where the probes are supposed to bind to. Then the intensities at
each spot as well as in the surrounding background are calculated and subtracted
from the spot intensity. Such background noise can for example be caused by
non-specific binding, i.e., adhering to sites on the surrounding (glas) area of the
spots [39]. Usually background noise is supposed to be additive and independent
of the true concentration of the gene in the sample given. Probes with negative
background subtracted intensities are excluded from further calculations [26].
Since the fluorescent markers Cy3 and Cy5 have diﬀerent fluorescent inten-
sities due to diﬀerent dye properties and light sensitivities, it is also necessary
to correct for noise and potential bias introduced by the diﬀerent dye measure-
ments separately. There are multiple ways of addressing this problem (see e.g.
[39]); in our case for measurements on LD8pack a set of 465 normalization genes
are used that were found to have stable intensity levels in this specific test set-
ting of tumor tissue analysis. For the other array types, all genes are used for
normalization. Based on these genes a normalization factor is calculated which
uses a combination of linear and lowess3 correction (see Agilent Feature selec-
tion software manual [2]). The product of the background subtracted signal
intensity and this normalization factor is then used to determine the log ratio
of the gene expression level in (2.1).
Each gene is measured in quintuple (for 44K arrays) or triplicate (for the
LD8pack array) on the single arrays and furthermore in some cases (e.g. for all
measurements on the Hu25K and the LD8pack array) a second dye-swap hy-
bridization is performed where the sample and the reference are labeled with the
reverse dye compared to the first hybridization. To combine replicate measure-
ments (first those within a single microarray and second those obtained form
the two hybridizations) of the Hu25K array the xdev approach [13, 63] has been
applied:
xdev =
I2 − I1￿
σ22 + σ
2
1
, (2.2)
where I2 and I1 are the intensity of the two dyes and σ22 and σ21 are the corre-
sponding variances of the estimated measurement errors.
However, this method of combining intensity measurements showed undesir-
able artifacts [26] and has therefore been replaced by error-weighted averaging
3Locally weighted scatterplot smoothing (lowess) is a regression technique for fitting
smooth curves to a data set via local fitting of polynomials [11].
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[63] for the more recent measurements performed on 44K and LD8pack arrays:
x¯ =
￿N
i=1 w(i) · x(i)￿N
i=1 w(i)
, (2.3)
where the x(i)s are the log ratio intensities of the i = 1, . . . , N measurements
(N ∈ {3, 5} for combining measurements within the array and N = 2 for com-
bining two hybridizations). The scalar weights w(i) are inversely proportional
to the approximated log ratio errors:
σx(i) ≈ log10(e) ·
￿
σ21
I21
+
σ22
I22
, w(i) =
1
σ2x(i)
.
2.3 Classification for the Prediction of Distant
Metastasis Development
We are now going to present a detailed definition of the classification problem
considered in this study. First, we define binary classification of tumor outcome
and misclassification errors that can occur in this context. Thereafter, we focus
on the special case of predicting distant metastasis development and the sever-
ity of diﬀerent kinds of misclassification errors, which will lead to a particular
performance assessment of classifiers defined in chapters 4 and 5.
Consider classification of tumor outcome where we distinguish only two
classes of possible outcome (binary classification):
positive: The disease is observed / progresses (the tumor develops metastases).
negative: The disease is not observed / does not progress (the tumor does not
develop metastases).
A tumor is represented by the expression of its genes measured on a microarray.
For classification we will, however, not consider all genes, but only a relatively
small subset, whose elements are called features. A classifier is a mapping defined
on the feature space X ⊂ Rn assigning to each feature vector in X , i.e., the vector
of gene expressions of the features, a class, an element of the space {positive,
negative}.
The class assigned to the feature vector does not necessarily correspond to
the tumor’s true class which leads to four possible results of the classification
with respect to the true classes:
Definition 1 (diagnostic table)
TRUE class
positive negative
TEST outcome positive true positive (TP) false positive (FP)negative false negative (FN) true negative (TN)
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Thus, a binary classifier can produce two kinds of errors: FP (type I error)
and FN (type II error). For measuring a classifier’s accuracy, we will use the
quantities sensitivity and specificity :
Definition 2 (sensitivity)
The false negative rate (FNR) is the relative amount of false negatives with
respect to all positive samples:
FNR =
FN
TP+ FN
.
Analogously, the true positive rate (TPR) or sensitivity is the relative amount
of true positives over all positive samples:
sensitivity =
TP
TP+ FN
= 1− FNR.
Thus, sensitivity measures a classifiers ability of recognizing positive samples
(sensitivity = 1 means that all positive samples are correctly classified).
Definition 3 (specificity)
The false positive rate (FPR) is the relative amount of false positives with
respect to all negative samples:
FPR =
FP
FP+ TN
.
Analogously, the true negative rate (FPR) or specificity is the relative amount
of true negatives over all negative samples:
specificity =
TN
FP+ TN
= 1− FPR.
Thus, specificity measures a classifiers ability of recognizing negative samples
(specificity = 1 means that all negative samples are correctly classified).
Please note that sensitivity = specificity = 1 represents perfect classification,
since in this case all samples (positive and negative ones) are correctly classified.
Therefore, we are aiming at maximizing these measures, which is similar to
minimizing the (overall) misclassification error.
Definition 4 (misclassification error)
The misclassification error (rate) e is the relative amount of misclassified sam-
ples with respect to all tested samples:
e =
FP+ FN
TP+ FP+ FN+ TN
=
FP+ FN
n
,
where n is the number of samples in the test set.
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When using this measure as an estimation of the true error rate of a clas-
sifier, both error types are considered equally important, whereas separately
measuring both kinds of errors by sensitivity and specificity allows for a more
flexible error access.
Consider now the special case of predicting whether a tumor will develop
distant metastases. The spread of tumor cells via the bloodstream or lymphatic
system to lymph nodes distant from the primary tumor or other organs is called
metastatic disease or distant metastasis [42]. A tumor formed by those cells is
called metastatic tumor, which in the case of breast cancer is usually found in
bones, lungs, liver or brain. The distinction of metastases in regional or distant
lymph nodes is less obvious than for the spread to other organs. For example,
(upper) arm lymph nodes are still considered regional lymph nodes to a primary
breast cancer tumor. In order to define the (most diﬃcult) upper line for lymph
node distances, we call supraclavicular lymph nodes distant and those below
the clavicula regional. By the term ‘metastasis’ we will in the following always
refer to distant metastasis, although it might not be explicitly stated.
In order to formulate the classification problem as a binary problem, we
define metastases development within 5 years as the positive and remaining
metastases free for at least 5 years as the negative outcome. Equivalently, we
refer to these two groups as high risk or low risk patients respectively, since a
positive outcome indicates a high risk of developing distant metastases, whereas
a negative outcome indicates a low risk thereof.
In this context, we consider type II errors worse than type I errors, i.e.,
misclassification of high risk patients is less accepted than misclassification of
low risk patients. This assumption arises from the clinical background we are
dealing with: overtreatment of low risk patients is stressful and costly, but un-
dertreatment of high risk patients might lead to considerable worse health or
even death. One possibility of addressing this problem is via assigning asym-
metric costs to the two kinds of errors [3, 36, 37, 61] and minimizing the total
costs caused by misclassifications. Another solution is to restrict the type II
error rate (FNR) to some predefined maximum during training. We will use
the latter method since we would like to control sensitivity, i.e., the frequency
of type II errors. This is not necessarily achieved by cost assignment since it
might be diﬃcult to define costs appropriately, i.e., such that we can make sure
to keep the type II error low.
2.4 Assessing Classifier Performance
In order to address the aforementioned problem, a classifier is trained on a set of
tumor samples with known true classes, a training set, optimizing specificity and,
more importantly, sensitivity on this set. The classifier is than validated, i.e.,
it’s performance is measured on a second data set,which also consists of samples
and their corresponding (true) classes, but is not used for training (validation
set). This is done to avoid overfitting, a typical problem in supervised learning
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(classification using training data sets for the classifier’s definition) [43, 50].
Overfitting means that the classifier is over adjusted to the training data, i.e.,
its parameters are optimized in such a way that it predicts the classes of the
training samples very well, but performs poorly on an independent data set.
This happens when the classifier does not capture the underlying relationship
of the samples to their classes, but rather random errors which occur, e.g., during
measurements (noise). Since microarray gene data usually consists of only very
few samples compared to the number of features (genes), one should put special
emphasize on avoiding overfitting [58]. One way of addressing this problem is
to use feature selection (see section 3.2), i.e., to reduce the feature space X
to only those genes that are most suitable for classification. Furthermore, the
evaluation of the classifier’s performance should not be done on the same set
the classifier has been trained on. This can either be achieved by validation on
an independent data set or cross-validation.
2.4.1 Cross-Validation
Cross-validation (CV) [6, 33, 52] is a procedure frequently used for classification
problems especially if there is only little data with known true classes available.
In this case one might want to use all samples for training and cannot exclude
some for subsequent validation. In order to still prevent overfitting, one possi-
bility is to repeatedly train the classifier on a (randomly chosen) subset of the
samples and use the remaining samples for validation. Thereby one can use all
samples for training and (cross-)validation at the same time.
The most common CV-method is k-fold-cross-validation which randomly
divides a given data set S into k subsets S1, . . . , Sk of approximately the same
size. In each CV-step i = 1, . . . , k the training set S \ Si is used to define a
classifier which is subsequently tested on the validation set Si. CV performance
is defined as the average performance over all CV-steps, i.e., the average over
the individual error measurements on the sets S1, . . . , Sk of left out samples.
The special case of a k-fold-cross-validation, where k = |S|, the number of
samples in the set, is called leave-one-out cross-validation (LOOCV).
Stratified cross-validation refers to cross-validation where in each CV-step
the training and validation set contain approximately the same relative fre-
quency of samples of each class. This method brings the advantage of generally
being less biased than non-stratified cross-validation [33].
2.4.2 ROC Curve Analysis
Receiver operating characteristics (ROC) curves are a very useful tool to visu-
alize and analyze the performance of binary classifiers [22, 35]. As discussed
before, a classifier’s performance is given by the measures sensitivity and speci-
ficity (each of which has a range of [0, 1]). The ROC space is defined as
[0, 1] × [0, 1], where a ROC point in this space represents a classifier’s false
positive rate (FPR = 1− specificity) on the first dimension and its true positive
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rate (TPR = sensitivity) on the second. The point (0, 1) in this space corre-
sponds to perfect classification, i.e. all samples are classified correctly as there
are no misclassified negative samples (specificity = 1) and all positive samples
are correctly classified (sensitivity = 1). The diagonal line from (0, 0) to (1, 1),
on the contrary, represents classification by random guessing: Consider classifi-
cation by coin tossing where samples are classified into the positive class with
probability p and into the negative class with probability 1− p, p ∈ [0, 1]. The
expected performance of this classifier results in a ROC point of (p, p), since
on average p of the negative samples are incorrectly classified and 1 − p of the
positive samples. In particular, a classifier classifying all samples as positive
corresponds to the ROC point (1, 1). Informally speaking, we can say that a
classifier gets worse the closer it gets to the diagonal and better the more it
approaches (0, 1). ROC points below the diagonal do practically not occur, be-
cause for a classification worse than chance we could then just invert the class
assignment.
If we now consider a classifier which does not assign a class to each sample but
rather a score representing the degree to which it belongs to the positive class, we
can calculate several ROC points for this classifier: Consider a (finite) training
set of samples x1, . . . , xn (with known true classes) and its corresponding scores
s1, . . . , sn. Without loss of generality, we can assume that the scores are in
ascending order, i.e., s1 < s2 < · · · < sn. Consider now a cutoﬀ value c, such
that a sample is classified into the positive class if and only if its score is greater
than c. In theory for each possible value of c ∈ R a classification result could
be obtained which is then compared to the true outcome to calculate sensitivity
and specificity values that define a ROC point. For practical reasons, only those
values are considered as cutoﬀ values which do occur as a score of an element
of the training set. For c = si this implies that the samples corresponding to
si+1, . . . , sn are classified positive and those corresponding to s1, . . . , si negative.
Hence, n+ 1 classifications can be obtained by considering the following cutoﬀ
values: s1− ε, s1, s2, . . . , sn for some ε > 0. The smallest and the largest values
result in the ROC points (0, 0) and (1, 1) respectively. Since we consider only
finite training sets we obtain a ‘wrinkled’ graph as the classifier’s ROC curve
(figure 2.1) on the training set.
Besides the obvious visual analysis and comparison of classifiers oﬀered by
this technique, a common measure to assess classifier performance via ROC-
curve analysis is to calculate the area under the curve (AUC). Since this mea-
sure is a portion of the unit square, it’s value lies between 0 and 1. However,
as classification below the diagonal (representing random classification) does
practically not occur, the AUC value can be expected to range between 0.5
(area under the diagonal) and 1. From a statistical point of view, the AUC is
equivalent to the probability that the classifier ranks a randomly chosen positive
sample higher than a randomly chosen negative sample. This is equivalent to
the Wilcoxon test of ranks [22].
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Figure 2.1: Example ROC curve. The diagonal line represents the expected
performance of random classification, the blue graph above the diagonal a clas-
sifier’s performance depending on diﬀerent cutoﬀ values.
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Chapter 3
Classification and Feature
Selection on Microarray Gene
Expression Data
3.1 Overview of Classifiers
Many diﬀerent classification methods have been developed and extensively tested
and studied in the area of microarray gene expression data analysis [39, 52].
Since this specific type of data usually consists of only relatively few samples
and a large amount of features, choosing an appropriate classification method
is important to obtain reliable predictions on the tumor outcome.
The term ‘classification’ is equivalent to the term ‘supervised learning’ [52],
where a data set with known true classes (learning set) is used as reference for
the assignment of class labels to the objects of interest (samples). The task is to
understand the underlying relation between the samples and the true class out-
come. In unsupervised learning, no predefined reference labels are used which
therefore have to be discovered from the data by the learning method. This
technique is especially useful if the possible outcome classes are not know a pri-
ori. In the following we focus on supervised learning (classification) describing
some of the most common methods and discuss their properties and especially
their suitability for the classification problem defined in section 2.3:
Given the binary classification problem of predicting tumor outcome (positive or
negative), we are aiming at minimizing misclassifications measured by the clas-
sifier’s sensitivity and specificity values. In particular, we control the sensitivity,
in that we set an upper bound for the maximum false positive rate (Definition 2).
Throughout this section we will use the following notation: For i = 1, 2, . . . ,m
genes and j = 1, 2, . . . , n samples, we denote the expression of gene i in sample
j by xij , where for each j the vector xj = (x1j , . . . , xnj)T is an element of the
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feature space X . For n = 1, we will also simply refer to the feature vector x1
by x. The outcome class vector will be denoted by y = (y1, . . . , yn), where each
element yj represents a class, an element of {1, . . . , N}. In the binary case,
the classes will also be denoted by +1 representing the positive class and −1
representing the negative class. The matrix of gene expressions per feature i
and sample j is given by X = (xij)i,j . Although here we use a matrix repre-
sentation, we will also denote the set of samples {xj | j = 1, . . . , n} by X which
will sometimes be more convenient than the matrix representation. The pair of
the set X and the corresponding outcome class vector y is called the learning
set L = (X, y).
A classifier is defined by a mapping C assigning to each feature vector x ∈ X
a class k = 1, . . . , N (or in the binary case k ∈ {−1,+1} instead of k ∈ {1, 2}).
The performance of a classifier (given by sensitivity and specificity) can be
measured on (subsets of) the learning set L, since it provides the true outcome
class for each sample x for comparison to the classification outcome C(x).
3.1.1 Naive Bayes
The basis of the naive Bayes classification method, is the Bayes’ Theorem:
For each class k ∈ {1, . . . , N} and each feature vector x ∈ X the conditional
probability P(k|x) of a sample with feature vector x belonging to class k is given
by:
P(k|x) = P(k) · P(x|k)P(x) ,
where P(k) is the probability of observing class k which is approximated by the
so called class prior p(k), e.g., the relative size of class k in the population of
interest or in the training data. P(x|k) is the probability of observing the feature
vector x within the elements of class k approximated by the class conditional
density p(x|k) and P(x) is the probability for observing x approximated by￿N
l=1 p(l) · p(x|l). In the case of naive Bayes classification, the features are
assumed to be independent and therefore the class conditional density p(x|k)
is equal to the product of the conditional densities for each feature: p(x|k) =￿m
i=1 p(xi|k), where xi is the gene expression level of gene i in the feature vector
x.
The Bayes classification rule is then given by assigning to x the class which
maximizes the so called posterior probability p(k|x), an approximation of P(k|x):
CB(x) = argmaxk p(k|x) = argmaxk
p(k) · p(x|k)￿N
l=1 p(l) · p(x|l)
.
Many classifiers can be view as variations of this simple classification rule with
respect to the estimation of the class conditional probabilities P(x|k) and the
assumption on independence of the features. Examples include discriminant
analysis, logistic regression, neural networks and classification trees [52].
17
Although the naive Bayes classifier is considered a rather simple classifier,
it nevertheless showed good empirical results in previous studies [16, 18, 52].
However, we did not employ this classifier on our classification problem because
we could not easily incorporate the requirement of restricting the amount of
falsely positive classified samples. One possibility to do this would be to use
cost asymmetry, but as discussed earlier, we restricted ourselves to the approach
of directly controlling the type II error instead of considering cost assignment.
Furthermore, assumptions on the prior probabilities and the underlying distri-
butions (depending on the true class labels) for obtaining the data variable X
have to be made. If those assumptions are not justified, estimating the proba-
bility measures yields a huge source of errors.
3.1.2 Nearest Centroid
For nearest centroid classification (NC) one uses a representative of each class,
a so called centroid ck ∈ X , k + 1, . . . , N , and classifies according to the dis-
tance of a feature vector x to each of the centroids. A classic nearest centroid
classifier searches for the nearest (defined by a given distance measure) centroid
cˆ to the feature vector x and classifies it to the same class as cˆ. The choice of an
appropriate distance measure should be considered depending on the classifica-
tion problem given. Possible choices are euclidean distance, city block distance
(l1 - norm) or 1 − correlation. Centroids can for example be constructed by
averaging over feature vectors of samples belonging to one class, but they do
not necessarily have to be derived from real data.
The nearest centroid classifier is also a rather simple classifier which is for
instance used in [5, 59, 60] for the classification of tumor samples. We are going
to present an analysis of this classifier for the prediction of tumor outome in
chapter 4, where we modify the classification rule in order to control the type II
error and constructed centroids by averaging over samples belonging to either
group.
3.1.3 k-Nearest Neighbor
The principle of k-nearest neighbor classifiers (kNN) is similar to the one of
nearest centroid classifiers. Given a feature vector x, instead of searching for
the nearest centroid, kNN determines those k samples of a set L1 ⊆ L (with
known true outcome) that are closest to x with respect to some similarity mea-
sure (the k nearest neighbors). In the classical context k is usually odd and x is
assigned to the class where the majority of these neighbors belongs to (majority
voting). Hence, L1 must contain at least one sample of each class.
Considering the fact that in some studies k = 1 neighbors have been deter-
mined optimal for classification [16, 18], the k-nearest neighbor classifier is well
comparable to the nearest centroid classifier: for |L1| = N , where L1 consists of
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exactly one element of each class, the kNN classification rule is even identical
to NC with the elements of L1 defining the centroids.
In order to obtain a more type II error sensitive classifier (for our binary
classification problem of predicting tumor outcome), we modified the kNN clas-
sification rule from majority voting to requiring that for the sample to be clas-
sified negative, l of the k neighbors have to belong to the negative class. Both
numbers, l and k, are optimized during a training procedure. This resulted in a
choice of k around 20− 25 (for l being greater than 0.9 ·k) during various train-
ings (results not shown). For such large numbers of k compared to standard
values of k < 7 used in the literature [16, 52], considerably higher computa-
tional costs compared to the nearest centroid classifier have to be taken into
account. Furthermore, since k is very large, the classification can be considered
more similar to the nearest centroid rule (with centroids taken as average over
multiple samples) than to classical k-nearest neighbor rule with small values for
k. Hence, we decided not to report results on this classifier in this study as it
does not give any further insights (compared to NC).
3.1.4 Support Vector Machines
Support vector machines (SVMs), first introduced by Vapnik in 1979 (see [9, 52]
for detailed information), were designed for binary classification problems with
a positive and a negative class, i.e., yj ∈ {−1,+1}, j = 1, . . . , n. If the data
is linearly separable, then there is a hyperplane H = {x ∈ Rn | w · x + b = 0}
separating the samples such that for all feature vectors xj , j = 1, . . . , n
w · xj + b ≥ 0 ⇔ yj = +1. (3.1)
w is the normal to the hyperplane H and |b|||w|| is the perpendicular distance
from H to the origin. The aim of support vector classification is to maximize
the margin (d++ d−), the sum of the distances of the hyperplane to the closest
positive (d+) and negative (d−) sample. By reformulating (3.1), we can define
two parallel hyperplanes H1 and H2 such that for all j = 1, . . . , n
H1 : w · xj + b ≥ +1, if yj = +1
H2 : w · xj + b ≤ −1, if yj = −1 (3.2)
or equivalently
yj(w · xj + b)− 1 ≥ 0. (3.3)
Since for H1 and H2 the distance to the origin is given by |1−b|||w|| and
|−1−b|
||w|| ,
respectively, the margin, i.e., the distance between the hyperplanes H1 and H2
is 2||w|| . Thus, one seeks to minimize the norm of w subject to the constraint
(3.3). Those sample points that lie on one of the two hyperplanes, i.e., for
which equality holds in (3.3) are called support vectors, because their removal
would change the solution of the minimization problem. By using the method
of Lagrangian multipliers it can be reformulated to the dual problem:
maxα
￿
j αj − 12
￿
l,j αlαjylyjxl · xj
s.t. αj ≥ 0,
￿
j αjyj = 0, j = 1, . . . , n,
(3.4)
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where xl · xj denotes the dot product of the two feature vectors xl and xj . The
solution of (3.4) is given by w =
￿
j αjyjxj , where only those samples j that
satisfy αj > 0 are support vectors.
In the non-separable case, one could either introduce slack variables into the
optimization problem or use kernel functions which implicitly map the sample
data into a (usually higher dimensional) euclidean space H: Given Φ : Rn → H,
the kernel function K is defined by
K(xl, xj) = Φ(xl) · Φ(xj). (3.5)
Here we need not explicitly know the mapping Φ to the possible infinite dimen-
sional space H. Commonly used kernels are:
Polynomial of degree p K(xl, xj) = (xl · xj + 1)p
Gaussian radial basis function (RBF) K(xl, xj) = e−||xl−xj ||
2/2σ2
Two-layer sigmoid neural network K(xl, xj) = arctan(κxl · xj − δ),
for which it has been shown that there exists a mapping Φ fulfilling (3.5).
Support Vector Machines are more sophisticated classifiers arising from the
area of machine learning, where the approach can be considered a black-box
algorithm. This is due to the use of Kernel functions which implicitly define a
mapping of the sample data into a (higher dimensional) euclidean space. By
varying the kernel function or the parameters to the kernel functions, the SVM
classifier often proved to be well adjustable to specific classification tasks [5,
61]. However, for the data sets that we used, samples seemed to be hardly
separable even in the infinite dimensional spaces used by RBF kernels with
varying parameter σ. Almost all samples were chosen to be support vectors; in
particular all positive samples which form a considerable smaller class than the
negative samples (data not shown). Even introducing soft margins (see [52, 61]),
i.e., slack variables, that allow for misclassification errors in the area close to
the separating hyperplane, could not solve this problem.
3.1.5 Classification Trees
Tree structured classifiers are constructed by repeatedly splitting the learning
set L = {(xj , yj) | j = 1, . . . , n} into subsets, which define the tree nodes, and
assigning a class to each terminal node. Classification trees diﬀer by the split-
ting rules they use, the stop-splitting criterion and the assignment of terminal
nodes to the outcome class. We will focus here on the CART (classification
and regression tree) classifier which is commonly used for microarray data clas-
sification [52]. The splitting rule is defined by maximizing a so called impurity
function: For any N-tuple of relative class frequencies p = (p1, p2, . . . , pN )1 with
pk ≥ 0 k = 1, . . . , N and
￿N
k=1 pk = 1 the impurity function f fulfills:
1Please keep in mind, that here again (as for the general description of naive bayes classi-
fiers) p denotes an approximation to the underlying probability measure P.
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1. f is maximal if all classes are equally frequent: p = ( 1N , . . . ,
1
N ).
2. f is minimal if there is just one class present in the learning set:
∃k ∈ {0, . . . , N} pk = 1.
3. f is symmetric in p: f(p) = f(p￿) if p and p￿ diﬀer only by the ordering of
their elements.
CART uses the gini index, defined by g(p) =
￿
k ￿=l pkpl = 1 −
￿
k p
2
k, as im-
purity function. Another common choice of an impurity function in tree clas-
sification is e.g. the information gain criterion (section 3.1.6). Based on this
function, we can define an impurity measure im for each tree node (represented
by T ⊆ L): im(T ) = f(p1(T ), . . . , pN (T )), where pk(T ) is the estimated condi-
tional probability (relative frequency) of observing class k in node T . Formally,
pk(T ) = πk
|{(x,y)∈T | y=k}|
|T | , where πk is the class prior probability. Each non
terminal node T is subdivided by a splitting rule s into TR and TL consisting of
the samples that are assigned to the right and left daughter node respectively.
The goodness of the split is measured by the decrease in impurity :
∆im(s, T ) = im(T )− |TR||T | · im(TR)−
|TL|
|T | · im(TL).
For each node T the splitting rule with biggest decrease in impurity is chosen
to determine the daughter nodes TR and TL. This procedures is repeated until
the full classification tree is grown (i.e. some stopping criterion is met). The
terminal nodes of this tree are assigned to a class, e.g., by majority voting of
the true class labels of the learning set.
Decision trees such as CART can be used as standalone classification meth-
ods, but their main benefit for the classification of gene expression data is in
using them as a base classifier for aggregation algorithms such as boosting [7, 16].
In that context especially so called decision stumps, i.e., trees that only perform
one split, are very popular since they have much less computational complex-
ity and have even been shown to outperform fully grown trees as the basis a
boosting algorithm [8].
3.1.6 Boosting
Boosting belongs to the class of aggregation predictors2, i.e., it aims at combin-
ing a number of classification hypothesis h1, h2, . . . , hT from a simple classifier
(weak learner). Thereby a the combined hypothesis
f(x) =
T￿
i=t
αtht(x)
is obtained, where the weights αi are assigned to each hypothesis during the
learning process [7, 40]. In each boosting iteration t = 1, . . . , T the training
2See [52] for an overview of aggregation predictors
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data is reweighted, which is been done by defining a new sample distribution
Dt depending on Dt−1 and the accuracy of ht. The performance of a rather
simple and therefore probably less accurate classifier can be improved by means
of combining the weak hypotheses obtained by the weak learner based on the
distributions Dt, t = 1, . . . , T . The most common boosting algorithm, first
introduced by Freund and Schapire [24], is AdaBoost (see [48] for a brief intro-
duction).
The algorithm is designed for binary classification problems where the learn-
ing set L is given by pairs (x1, y1), . . . , (xn, yn), xj being an element of the fea-
ture space X for the jth sample and yj ∈ {−1,+1} the corresponding class.
Starting with an initially uniform distribution D1(j) = 1n , j = 1, . . . , n the fol-
lowing steps are preformed for each iteration t = 1, . . . , T :
Algorithm 1 The AdaBoost algorithm
1. Training of the weak learner using the distribution Dt and obtaining the
weak hypothesis ht
2. Calculation of the training error: ￿t = PDt(ht ￿= y) =
￿
{j:ht(xj) ￿=yj}Dt(j)
3. Determination of the weight αt = 12 ln
￿
1−￿t
￿t
￿
4. Update of the distribution Dt by Dt+1(j) = Dt(j)exp(−αtyjht(xj))￿
lDt(l)exp(−αtylht(xl)) ,
j = 1 . . . , n
Common choices for the weak classifiers are classifications trees or decision
stumps (one dimensional trees).
The concept of the AdaBoost classifier has already been introduced in 1995
(by Freund and Schapire [24]) and since then constantly been improved and
modified (see e.g. [49]). We will, however, consider the basic version defined
here, which suﬃces for our purposes since we will use this classifier for feature
selection only (see section 3.2.3). It can be shown that the training error of the
AdaBoost algorithm (and also that of other boosting algorithms) converges to
zero if the weighted empirical error of the weak learner can be guaranteed to be
smaller than 12 − γ, γ > 0 [40]. Furthermore, there are studies that empirically
show slow over-fitting behavior, although this cannot be proved theoretically
[7, 38].
3.1.7 Conclusion
The classifiers presented here are commonly used and compared against each
other within the area of classifying microarray gene expression data. It has
been shown that each of them is – in general – useful to produce a meaningful
classification of this type of data, although slight diﬀerences in performances can
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be observed depending on the (learning) data set used for classification [5, 15,
16, 30, 52]. However, not all of them are suitable for the particular classification
problem studied here, where we want to control the classifier’s sensitivity (and
therefore type II errors) directly. This is the case for Bayes classifiers as well
as for kNN classifiers, that require an unusually large number of neighbors in
order to meet the requirement of controlling sensitivity. Another problem is
that the samples of the diﬀerent classes in the learning data we used seem to
be strongly overlapping and thus the SVM approach is not applicable since the
problem could not be solved by using various kernels that (implicitely) map the
data into a higher dimensional space. Furthermore, Hand [29] pointed out that
for example in the area of bioinformatics, sophisticated classification methods
often provide only little improvement compared to more simple approaches.
Therefore, we decided to consider only one kind of classifier: the nearest centroid
classifier and focus on the comparison of feature selection methods instead. In
chapter 4 various modifications of the NC classification method are presented,
based on that MammaPrint algorithm developed in [60]. Their performances on
a learning set are compared against each other to determine an overall superior
NC-classifier.
We then use this classifier to analyze the influence of diﬀerent feature selec-
tion methods on its performance (see chapter 5).
3.2 Overview of Feature Selection Methods
The extraction of microarray gene expression data usually provides a huge
amount of features (genes) compared to a very low number of samples. Since
diﬀerent genes encode diﬀerent functionalities in the human DNA, not all of
them influence the outcome one would like to predict. A feature is considered a
good predictor if it either has a high predictive value by its own or in conjunc-
tion with some other subset of features. In order to filter for those genes and
disregard the ones with low predictive value, many diﬀerent feature selection
methods have been established in the literature. They are considered very valu-
able since they do not only reduce the dimension of the classification problem
but also filter out noise introduced by non predictive genes. Classification on a
subset of selected features therefore becomes faster and – most importantly –
more accurate (see e.g. [14, 15, 28, 34, 52]). Considering the prediction of breast
cancer outcome on the basis of microarray gene expression levels, diﬀerent sets
of predictive features have been presented in the literature with a remarkably
low overlap of almost zero genes [41]. This might be caused by the fact that
gene expressions vary a lot subject to the training data the selection is based
on. It is therefore very important to choose an appropriate feature selection
method which operates prior or parallel to classification.
We will now give a short overview of some common feature selection pro-
cedures that might be useful for our classification problem. Generally, feature
selection methods can be subdivided into three main classes: filter, wrapper and
embedded methods [28, 52]. Filters select features in a preprocessing step, inde-
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pendent of the classifier of interest, whereas wrappers and embedded methods
use the classifier for measuring the predictive power of the features selected.
Simple filter methods include rank ordering of features according to correla-
tion coeﬃcients (section 3.2.1) or by construction of test statistics that identify
features whose gene expression values diﬀer significantly for the classes in the
training set. For binary classification problems, it is easy to define test statistics
for determining features whose feature vectors come from a diﬀerent distribu-
tion in the two classes. Commonly used tests are, among others, the T-test, the
nonparametric Wilcoxon test or the Kolmogorov-Smirnov test [34, 52].
Wrapper methods on the other hand are usually based on sequential forward
or backward selection (SFS or SBS) respectively, i.e., they start with an empty
(or complete respectively) set of features and subsequently add (or remove re-
spectively) one feature that results in the greatest improve of performance.
Embedded methods are similar to wrappers except for the fact that they
incorporate feature selection during training of the classifier, i.e., they perform
implicit feature selection.
Compared to filters wrapper and embedded feature selection methods are
sometimes critized to be more greedy and computationally complex [28]. Their
advantage lies in the connection to the classifier of interest whose performance
can therefore be directly influenced (improved), which is not guaranteed when
using filters. On the other hand the involvement of the classifier is always accom-
panied by the risk of overfitting (see section 2.4). Good wrapper and embedded
methods should therefore address both problems: computational complexity
and overfitting.
In the following we describe some popular embedded feature selection meth-
ods, that appear to be suitable for improving nearest centroid classification:
nearest shrunken centroid (section 3.2.2), adaboost (section 3.2.3) and the lasso
(sections 3.2.4 and 3.2.5). For our purposes, however, we use some of these
methods as the basis of a sequential forward selection algorithm only (see chap-
ter 5).
3.2.1 Correlation to Disease Outcome
A (computationally) fast approach for selecting features is to consider the cor-
relation of each gene to disease outcome [15, 28, 52], represented by a vector
s of n binary components, where n is the number of samples in the learning
set. Each sample x1, . . . , xn is associated with its true outcome: Typically +1
represents positive and −1 negative outcome. For each gene the (Pearson) cor-
relation (see Appendix B for definition) of its expression levels on the n samples
to s is calculated and only those genes with high correlation (in absolute value)
to the outcome are selected. For example, one could choose those genes whose
correlation to disease outcome is unlikely to be observed in randomized data or
simply the first k features accoring to the rank order.
The approach of using correlation to disease outcome for feature selection
has, among others, been used in [60] and is the basis of the MammaPrint test.
24
In this case disease outcome is represented by the binary survival vector s whose
entries are 1 for good prognosis (i.e. low risk sample) and 0 for poor prognosis
(i.e. high risk sample). By using Monte Carlo methods to generate randomized
data (from the training data set), the authors decided to use a cut-oﬀ value of
0.3 in absolute value to select for features that are highly correlated (or anti-
correlated) with disease outcome. By selecting those features whose correlation
to disease outcome was either less than −0.3 or greater than 0.3 they obtained
a set of 231 genes which was rank ordered according to their correlation to s.
3.2.2 Nearest Shrunken Centroid
The nearest shrunken centroid method (NSC) was first introduced in 2002 by
Tibshirani et al. [56], applied to DNA microarray data in 2003 [57], and there-
after modified by Wang et al. [62]. The main idea of this method is to ‘shrink’
the centroids of the diﬀerent classes to the overall centroid (a centroid built
over all samples independent of their classes) and thereby filtering out those
genes that have a low predictive value, i.e., have similar values in all classes.
For i = 1, . . . ,m genes and j = 1, . . . , n samples let Ck be the indices of the nk
samples in class k ∈ {1, . . . , N}. The class centroid for class k at the i-th entry
representing gene i is defined by:
x¯ik =
￿
j∈Ck
xij
nk
and the overall centroid by
x¯i =
n￿
j=1
xij
n
.
Let
dik =
x¯ik − x¯i
mk · si ,
where si =
￿
1
n−2
￿N
k=1
￿
j∈Ck (xij − x¯ik)2 is the within-class standard devi-
ation and mk is given by mk =
￿
1
nk
− 1n . dik is shrunken by a number ∆
towards zero: d￿ik = sign(dik)(|dik|−∆)+, which causes the k-th centroid to be
shrunken towards the overall centroid:
x¯￿ik = x¯i +mk · si · d￿ik.
The authors called this shrinkage method soft thresholding : Each dik is reduced
by ∆ in absolute value and set to zero, if its absolute value is less than ∆.
Since this parameter also determines the shrinkage of the class centroids, the
choice of ∆ is crucial for the feature selection procedure: If it is too large, a lot
of information is lost, since the centroids are set equal to the overall centroid
in many components, which do therefore not contribute to classification any
more. If it is too small, the centroids remain almost unchanged and unpredictive
features are not filtered out. The optimal ∆ is determined via minimization of
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training, test or cross-validation error, where the classification rule for a sample
x is defined by:
C(x) = l, s.t. δl(x) = min
k
δk(x), l ∈ {1, . . . , N}, (3.6)
where δk(x) =
￿p
i=1
(xi−x¯￿ik)2
s2i
−2 · log πk (πk being the class prior probabilities).
3.2.3 Feature Selection via Boosting
The beneficial characteristic of the AdaBoost algorithm (section 3.1.6) is its
ability to iteratively adapt a classification model to ‘outlier’ samples, i.e., sam-
ples that would often be misclassified by the weak learner without distribution
adjustment. When using this algorithm for feature selection, it is presumed
that it iteratively selects features that contain qualitatively new information,
i.e., that would be appropriate to pick up those ‘outlier’ samples that have been
misclassified by the combined classification rule defined on the set of currently
selected features. One approach of using AdaBoost for feature selection has
been introduced in [14]. The author proposed to use decision stumps based on
the information gain criterion to select for a new feature to be added to the
set of (already) selected features in each boosting iteration step. A learning
classifier is used to find the optimal set of features which is defined by the set
which maximizes the classifier’s (training or validation) performance. The same
learning classifier is also used to identify ‘outlier’ samples, in that the weak hy-
potheses are given by it’s classification results. Therefore, for each iteration step
t = 1 . . . , T the decision stump is only used to select the feature with biggest
information gain on the sample distribution Dt out of the set of previously non-
selected features. The selection of features due to the information gain criterion
is comparable to that of the gini index [46], also it originally evolved in the field
of information theory. For the definition of information gain we need first need
to declare the following quantities:
Definition 5 (information entropy)
The entropy H of a discrete random variable Z with values V1, . . . , VN is defined
by
H(Z) = −
N￿
k=1
P(Z = Vk) log2(P(Z = Vk)).
Analogously, the entropy of the set L = (X, y) with class labels k = 1, . . . , N
is given by
H(L) = −
N￿
k=1
p(k) log2(p(k)),
where p(k) is an estimate of the probability that a sample belongs to class k.
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A commun estimate of p(k) is given by the relative amount of samples j
whose true class label is k: p(k) = |{j∈{1,...,n}|yj=k}|n , k = 1, . . . , N , where n is
the number of samples in L.
The definition of entropy of our learning set L is deducted from the general
definition (for random variables) by considering the class variable y of L as the
realization of a random variable. Similarly, we define the conditional entropy
for random variables and for the realization given by y and the classification
outcome C(X):
Definition 6 (conditional information entropy)
For two discrete random variables Z1 with values V1, . . . , VN and Z2 with values
W1, . . . ,WM , the conditional entropy H(Z2 | Z1) is given by
H(Z2 | Z1) =
N￿
k=1
P(Z1 = Vk)H(Z2 | Z1 = Vk),
where H(Z2 | Z1 = Vk) =
￿M
l=1 P(Z1 = Wl | Z2 = Vk) log2 P(Z1 = Wl | Z2 =
Vk), k = 1, . . . , N .
Analogously, the conditional entropy of L given the test outcome C(X) (of
the classification C applied to X) is defined by
H(L | C(X)) =
N￿
k=1
p(C(X) = k)H(L | C(X) = k)
= −
N￿
k=1
p(C(X) = k)
N￿
l=1
p(l | C(X) = k) log2(p(l | C(X) = k)),
where p(C(X) = k) and p(l | C(X) = k) are estimates of the probabilities for the
classification outcome k and the true outcome l provided that the classification
outcome is k, respectively.
p(C(X) = k) and p(l | C(X) = k) are usually estimated by the observations
in the learning set L: p(C(X) = k) = |{j∈{1,...,n}|C(xj)=k}|n , k = 1, . . . , N and
p(l | C = k) = |{j∈{1,...,n}|C(xj)=k, yj=l}||{j∈{1,...,n}|C(xj)=k}| , k = 1, . . . , N, l = 1, . . . , N .
Definition 7
For two discrete random variables Z1 with values V1, . . . , Vn and Z2, the infor-
mation gain IG(Z2 | Z1) of Z1 to Z2 is given by
IG(Z2 | Z1) = H(Z2)−H(Z2 | Z1).
Analogously, the information gain for the learning set L when applying clas-
sification rule C is given by
IG(L | C(X)) = H(L)−H(L | C(X)).
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For concrete realizations (y and C(X)) of the random variables this quantity
can be interpreted as a measure of reduction of the expected entropy caused by
partitioning of the samples in L according to C.
Given a training set consisting of a matrix X of measurements for n samples
and m genes and a corresponding class vector y = (y1, . . . , yn) ∈ {−1, 1}n,
maximizing the information gain using a classification tree is equal to minimizing
the conditional entropy
H(L | Ci(X)) = P(Ci(X) = −1) ·H(L | Ci(X) = −1)
P(Ci(X) = +1) ·H(L | Ci(X) = +1)
over all features i (that have not been selected yet). Ci denotes the classification
according to the value of expression of gene i. This is equivalent to the splitting
rule described in 3.1.5 since for decision stumps the first (and only) split defines
the final classification (both children nodes are terminal).
Here a simple decision rule is used: Given a threshold value x˜i and a sample
xj = (x1j , . . . , xmj)T
Ci(xj) =
￿ −1 if xij < x˜i
+1 else
3.2.4 Feature Selection via the Adaptive Lasso
The ‘least absolute shrinkage and selection operator’ (Lasso) [54] is based in the
usual regression setting where the sample data X is assumed to be standardized,
i.e.,
￿
j xij
n = 0 and
￿
j x
2
ij
n = 1, i = 1, . . . ,m, and the class observations of y are
assumed independent or conditionally independent given X. If we additionally
assume y to be centered, i.e., y¯ = 0, then the lasso estimate βˆ = (βˆ1, . . . , βˆm) is
given by
βˆ = argminβ
￿n
j=1 (yj −
￿m
i=1 βixij)
2
s.t.
￿m
i=1 |βi| ≤ λ.
(3.7)
The parameter λ ≥ 0 is called tuning parameter since it determines the amount
of shrinkage of the solution of the unconstraint version of (3.7), the ordinary
least square estimate βˆ0, towards zero. If λ is chosen appropriately, the algo-
rithm therefore implicitly performs variable selection, since only those features
i such that βˆi > 0 contribute to classification.
An amplification of this algorithm is the adaptive Lasso [65] defined by
βˆ = argminβ
n￿
j=1
￿
yj −
m￿
i=1
βixij
￿2
+ λ
m￿
i=1
wi|βi|, (3.8)
for some weight vector w, e.g., wi = 1|βˆ0i |γ
, i = 1, . . . ,m for some γ > 0. For
w = (1, . . . , 1) the model coincides with (3.7).
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3.2.5 Feature Selection via the Adaptive Lasso for Cox’s
Model
The proportional hazards model or Cox’s model is given in the setup of survival
data. This means that instead of the learning set L = (X, y) the input data
consists of the triple (s,X, δ), where s is the survival vector (encoding disease
free time) and δ a vector of censoring events. For δj = 1 the survival time sj
corresponds to the actual time until disease development is observed, whereas
for δj = 0 the follow up of the j-th sample ended at time sj until which no
disease development has been observed. As before we assume the input data
X to be standardized and denote the failure times (disease development at a
sample) by t1 < · · · < tk. Then the Cox model [12] is given by
h(t | X) = h0(t)eβTX ,
where h(t | X) is the hazard at time t given X and h0 is a baseline hazard
function. For simplicity we do not consider ties, i.e., at each failure time tl
there is exactly one failure. The hazard function estimates the survival rate of
the individuals under risk given the feature vectors in X starting from time t.
In order to estimate the value of h(t | X) the parameter β is estimated through
maximization of the partial likelihood
L(β) =
￿
{j|δj=1}
eβ
T xj￿n
l=1 e
τjβT xl
, (3.9)
where τj = ( sl≥sj )l is a binary vector determining the individuals at risk at
time tl − 0 defined by
sl≥sj =
￿
1 if sl ≥ sj
0 else.
Again we define the Lasso estimate by restraining the solution βˆ0 of (3.9) via￿
i |βi| ≤ λ (for some λ ≥ 0) and the corresponding aadaptive Lasso estimate
for Cox’s model by weighting the elements of β which leads to
￿
i wi|βi| ≤ λ
for some weight vector w. The maximization of the partial likelihood in (3.9)
is equivalent to the minimization of the negative log partial likelihood and we
therefore define the adaptive Lasso estimate for Cox’s model as the solution of
the following equation [55, 64, 66]:
βˆ = argminβ − ln (L(β)) + λ
m￿
i=1
wi|βi|. (3.10)
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Chapter 4
Testing Nearest Centroid
Classifiers
The basis of the following investigations will be the MammaPrint algorithm, a
nearest centroid classifier for the prediction of tumor outcome, which is described
in detail in [60]. We will consider modifications of this classifier with respect
to similarity measures, classification rules and the construction of centroids.
However, in this section we will not change the set of features selected for
MammaPrint; this problem will be addressed later in chapter 5.
4.1 MammaPrint
The MammaPrint algorithm has been developed in 2002 on the basis of 78
samples of lymph node negative1 breast cancer patients younger than 55 years.
These samples were subdivided into two groups of low risk and high risk patients
depending on whether they developed distant metastasis within 5 years. Ini-
tially, for each group a gene expression profile (centroid) was defined consisting
of the average expression across a set of 70 preselected features (see section 3.1
and [26]). In principle this algorithm works just as a classical nearest centroid
classifier except for the fact that the low risk profile is used as the only cen-
troid (disregarding the high risk profile) and there is a shift incorporated in the
classification rule: A sample is classified as low risk, if the cosine correlation2
to the low risk profile is greater than 0.415.3 This value was determined by
cross-validation in order to reduce the type II error to 10% (i.e. misclassifying
a high risk patient as low risk) at the expense of increasing the type I error
(i.e. misclassifying a low risk patient as high risk), which correspondes to as-
sociating a higher cost to the type II error than to the type I error. However,
1Lymph node negative means that no adjacent lymph nodes are aﬀected by tumor metas-
tases.
2See Appendix B for definition
3A classical nearest centroid classifier would set this value to 0.
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the main benefit of the MammaPrint classification compared to clinical charac-
teristics used within the guidelines of NIH [27] and St. Gallen [20] and to the
Adjuvant!Online system [47], is the reduction of the type I error rate since this
means saving a lot of people from having to undergo chemotherapy [10, 59, 60].
4.2 Test Settings
Just like the MammaPrint classifier we aim at classifying tumor gene data ac-
cording to their probability of developing distance metastasis considering two
classes: high risk and low risk. For the clinical data available, we define a patient
who did not develop metastasis within 5 years to belong to the low risk group
and patients who did develop metastasis in this time to belong to the high risk
group. For this purpose we will define several nearest centroid classifiers, which
will be compared on two levels:
• The classifier is tuned by optimizing its parameters on a training set.
Subsequently its performance is measured on a validation set being inde-
pendent from the training set.
• A (complete) leave-one-out cross-validation (LOOCV) is performed opti-
mizing the classifier’s parameters in each cross-validation step and then
applying the classifier (defined by the optimal parameters) to the sample
which was left out.
Although it has been shown that the leave-one-out method is in general inferior
to k-fold-cross-validation (for k = 5 or 10) for the estimation of the true classi-
fication errors (on independent sets) [6, 33], it is more suitable for our purpose,
as we can therefore perform a complete cross-validation which is reproducible
whereas even 10*10-fold cross validation produces insuﬃciently stable results
for properly comparing the classifiers (data not shown).
Using these methods we investigate the nearest centroid classifiers consider-
ing three aspects:
• What is the impact of using diﬀerent gene expression profiles as centroids
(based on diﬀerent data sets) on the classifier’s performance?
• Is classification based on a low risk profile only (as is done for MammaPrint)
optimal or can we improve the classifier by introducing other (additional)
profiles and thereby defining new classification rules?
• What is the impact of using cosine correlation compared to other corre-
lation coeﬃcients such as Pearson, Spearman or Kendall as a similarity
measure for the nearest centroid classifier?
4.2.1 Data
For the following tests we used the NEJM260 and the Transbig data as training
and validation sets, where NEJM260 is used for validation of classifiers that have
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been trained on Transbig and vice versa.4 Here training refers to parameter op-
timization of the nearest centroid classifier (see section 4.2.3). The conjunction
of training and validation set is called the learning set L. NEJM260 comprises in
total 260 samples from which we excluded those that had insuﬃcient follow-up
time and those that originated from the Nature study, i.e., the data set used in
[60] for the definition of MammaPrint (see Appendix C). This resulted in a set
of 176 remaining samples, 38 being low risk and 138 high risk, which we will refer
to as NEJM176. The Transbig data set consists of 324 samples, where we also
excluded those that did not have enough follow up time and we will therefore
only consider a total of 283 samples (simply referd to as Transbig) containing
48 low risk and 235 high risk samples. We consider a sample to have insuﬃcient
follow-up time, if no metastases have been diagnosed and the follow-up was less
than 5 years. This equates to the exclusion of samples for which it is unknown,
whether there has been metastasis development within a 5-year time period.
4.2.2 Construction of Centroids
First we constructed gene expression profiles that serve as centroids using the
78 samples of the Nature study (where 34 belong to the high risk and 44 to
the low risk group). Here, we did not use the original MammaPrint (low risk)
profile, which has been obtained by combining the gene expression of the low
risk samples measured on the Hu25K array and using the signal to noise metric
xdev [26] for calculating gene expression levels. Later it has been recalculated by
analyzing the low risk samples on a ‘miniarray’, LD 8-pack array, custom-built
for the MammaPrint test and employing the (log ratio) error-weighting approach
presented in section 2.2 [26]. We built new centroids based on the Nature
samples using the error-weighting method but measured on the Hu25K array,
because the high risk samples have not been reanalyzed on the LD8pack array.
For comparison, we also extracted profiles from the Transbig data which was
measured on the LD8pack array. In the following we will refer to these profiles
by nLR, nHR, tLR and tHR (see table 4.1 for an overview of the definitions).
Please note that the centroids built on the Nature data are independent of the
profile name description
nLR nature Low Risk profile averaging over expression levels
of the Nature low risk patient group
nHR corresponding transbig High Risk based on the Nature
data.
tLR transbig Low Risk profile averaging over expression lev-
els of the Transbig low risk patient group
tHR corresponding transbig High Risk profile based on the
Transbig data
Table 4.1: Profiles used as centroids
4See Appendix C for an overview of the data sets used.
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data sets used for training and validation. When evaluating the test results, we
should keep in mind that this does not hold true for tLR and tHR.
4.2.3 Classification Rules
Depending on the profiles used, diﬀerent kinds of prediction rules for nearest
centroid classifiers have been established depending on the parameters thres-
hold and gap and the kind of profile used (table 4.2). Although basing the
classification on just one (low risk) profile has been considered suﬃcient for the
MammaPrint algorithm, we would like to also incorporate classifiers based on
two profiles into the tests. For this purpose, we defined two new classification
rules: R3 and R4. The former is the classification rule being most similar to the
classical nearest centroid rule: A sample is classified low risk, if its similarity is
at least gap counts greater than the similarity to the high risk profile. The last
rule, R4, is a combination of R1 and R3: it assigns a sample to the low risk class
if the conditions of R1 and R3 hold true for some values of gap and threshold.
Name Profile Parameter Rule
R1 LR threshold If the sample’s correlation to the low
risk profile is greater than threshold,
the sample is classified low risk and
high risk otherwise.
R2 HR threshold If the sample’s correlation to the
high risk profile is greater than
threshold, the sample is classified
high risk and low risk otherwise.
R3 LR, HR gap If the diﬀerence between the sam-
ple’s correlation to the low risk pro-
file and the correlation to the high
risk profile is greater than gap, the
sample is classified to be low risk
and high risk otherwise.
R4 LR, HR threshold, gap If the sample’s correlation to the low
risk profile is greater than threshold
and the diﬀerence between this cor-
relation and the correlation to the
high risk profiles is greater than gap,
the sample is classified to be low risk
and high risk otherwise.
Table 4.2: Classification rules for the modified nearest centroid classifier
Graphically, these classification rules can be view as a linear separation of
the 2-dimensional space which is the range of the mapping Φ : X ← R, x ￿→
(sim(x,LR), sim(x,HR)), where sim(x,LR) and sim(x,HR) is the similarity
measure of the sample x ∈ X to the low risk and the high risk centroid, respec-
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tively. Figure 4.1 shows the separation of Φ(X ) according to a threshold based
rule (horizontal line) and a gap based rule (diagonal line). The gray areas right
of the threshold line and below the gap line indicate samples that would be clas-
sified low risk by either of the two; the intersection of the two areas (dark gray),
represents samples that would be classified low risk by a classifier applying R4.
Figure 4.1: Example of a binary classification problem: blue and pink dots rep-
resent samples of two diﬀerent classes (high risk and low risk). The samples sim-
ilarity to the LR-centroid is plotted against their similarity of the HR-centroid.
Classification separates the space according to threshold-based (vertical line),
gap-based (diagonal line) or threshold-gap-based (vertical and diagonal line)
classification rules.
4.2.4 Similarity Measures
Considering nearest centroid classification, naturally the question of how to
choose an appropriate distance or similarity measure arises. In the particular
problem setting of classifying tumor or, in general, disease outcome one common
approach is using correlations. Besides the commonly known (standard) corre-
lation coeﬃcient (also known as Pearson correlation coeﬃcient), other measures
of interrelation have been developed and are frequently used in the literature
such as Spearman rank, Kendall’s tau or cosine correlation (see Appendix B for
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definitions). For MammaPrint the cosine correlation coeﬃcient is used which is
simply defined as the cosine of the angle between two vectors.
4.2.5 Parameter Optimization
For determining the optimal training parameters (gap and/or threshold) we
employed a similar accuracy measure5 as has been used in [60] for MammaPrint:
Considering only those classifiers whose false negative rate (FNR) is at most
10%, i.e., sensitivity = 1 − FNR ≥ 0.9, the one with highest specificity is
considered optimal.6 This can be view as the following optimization problem:
max
param
specificity
s.t. sensitivity ≥ 0.9
(4.1)
In case there are two parameters defining classifiers with equal specificity (com-
plying with the constraint), we will choose the one with higher sensitivity. If the
classifiers also agree on this measure, they are considered equally good and both
parameters are stored as optimal. However, for validation we will only use the
biggest (or smallest for R2, respectively) optimal parameter. This again is done
to emphasize the importance of achieving high sensitivity: A higher threshold
or gap parameter (or smaller threshold parameter for R2, respectively) results
in higher sensitivity accepting a lower specificity measure.
We chose this method in contrast to the standard approach of measuring
the misclassification error rate, because we want to put special emphasis on the
FNR (type II error rate), i.e., the rate of misclassifying a high risk patient as
low risk. By restricting the FNR to 10%, we make sure that in the training
set at most 10% of the high risk patient are incorrectly classified. One could
argue about how to choose this threshold value. Here we decided to take 10%
since this coincides with the threshold defined in [60] for the development of
MammaPrint. We think it is a reasonable choice, because it keeps the type II
error rate very low without demanding too much of the classifier, i.e., it is still
allowed to misclassify some potential ‘outlier’ samples.
For classification rules R1, R2 and R3 the optimization has been imple-
mented by an approach based on the calculation of ROC curves: Since for
these rules, there is only one parameter to be optimized, we could easily extract
a vector of scores, which estimates the probability for a sample to be classi-
fied positive. This is been done by calculation of the similarity of the samples
x = (x1, . . . , xn) to the centroid(s) and calculating the scores depending on the
classification rule:
R1 s(x) = (− similarity(xj ,LR))j
5Definitions of the error measures can be found in section 2.3
6Please note that any of our classifiers will fullfill this constraint for suitable parameters
as one could for instance force the sensitivity to be 1 by just classifying all samples positive,
i.e., high risk
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R2 s(x) = (similarity(xj ,HR))j
R3 s(x) = (similarity(xj ,HR)− similarity(xj ,LR))j
The vector of scores s is then ordered in ascending order and for each entry
the classifier’s sensitivity and specificity measure is calculated (where −sj (for
R1 and R3) or sj (for R2) are taken as parameter values, respectively). Of
the resulting sensitivity and specificity vectors, sens and spec, we extract those
indices I = {k, k + 1, . . . , n} whose sensitivity values are above the constraint
of 0.9. The index set I is of that form because of the ordering of s:
Suppose s1 < · · · < sn. Using the score value sj as cutoﬀ (see section 2.4.2), the
first j samples with scores s1, . . . sj are classified negative and the rest positive.
Thus, changing to sj+1 as cutoﬀ, results in a change of the class of the sample
corresponding to sj+1 from positive to negative. Therefore, if the true outcome
of this sample is positive, it is now misclassified and specificity decreases, but
sensitivity remains unchanged since it only measures falsely positive classified
samples. If the true outcome class is negative, then sensitivity increases since
the former misclassification has been corrected (specificity remains unchanged).
Hence, sensj+1 ≥ sensj (and equivalently specj+1 ≤ specj) holds for all j =
1, . . . , n− 1.
Given I, we then take the maximum of specj over all j ∈ I which is obtained
at j = k, . . . , l for l ≤ n. By the previous considerations we get that
speck = · · · = specl = max(specj | j ∈ I)
and
sensl ≥ · · · ≥ sensk,
where equality only holds if the samples xk, . . . , xl are equal with respect to the
similarity measure to the centroid(s). We therefore set s∗ = −sl (for R1 and R3)
or s∗ = sl (for R2) as the optimal parameter value. For storage s∗ is rounded
at the fourth post decimal position either up (for R1 and R3) or down (for R2).
This is due to the fact that the classification rules are defined by s(x) > s∗; so
by rounding s∗ up (or down for R2) the classification result remains unchanged
on the training set (except if there would be another sample score being at most
10−4 greater than s∗).
For R4 on the other hand a more greedy approach has been applied since
one cannot calculate such a probability score (as the classification rule depends
on two criteria that have to be fulfilled at the same time). Here we tested for a
step length of 0.01 within the maximal possible range [−2, 2] and [−1, 1] every
parameter value for gap and threshold, respectively. Please note that using
this approach for the before mentioned classification rules would result in an
optimal parameter of sˆ = ￿sl/100￿ · 100, where sˆ and s∗ determine the same
classification on the training set, again up to rounding errors. Here, we obtain
a less accurate parameter value than for the previous method which is due to
the extensive computational eﬀort caused by the larger amount of parameter
values that need to be tested.
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Correlation Threshold Gap Diagnostic Table Specificity Sensitivity
Cosine -1.0 - 0.42 0.46 - 0.49 35 753 63 0.4565 0.9211
Pearson -1.0 - 0.27 0.38 - 0.4 35 783 60 0.4348 0.9211
Spearman -1.0 - 0.4 0.41 35 813 57 0.4130 0.9211
Kendall -1.0 - 0.29 0.29 - 0.3 35 813 57 0.4130 0.9211
Table 4.3: Performance of the nearest centroid classifaction on the NEJM176
training set applying R4 with profiles nLR and nHR. Optimal parameters are
tested within the maximal possible ranges of [−1, 1] for threshold and [−2, 2]
for gap. The test step length was chosen to be 0.01 for both.
4.3 Results
Using the Matlab program [53] we implemented tests on nearest centroid clas-
sifiers considering the three characteristics defined before: we performed a val-
idation (and cross-validation) on each classifier being defined by (1) the data
the centroid has been extracted from, (2) the classification rule used and (3) the
similarity measure applied.
Already during training it turned out that apparently R4 does not produce
very meaningful classifiers as it shows that for most test cases the best way
to choose the parameters is such that the classification rule reduces to R3: As
can be seen in table 4.3, for each distance measure the optimal threshold lies
within some interval [−1, x] which means that all classifiers with threshold values
in this range (and corresponding optimal gap values) perform equally good,
i.e., produce the exact same classification on NEJM176. Since the condition
‘similarity to low risk profile > −1’ is always fulfilled, a threshold value of −1
does not contribute to the distinction of the sample classes. Hence, this classifier
equates to the one using R3 on the same profiles. We therefore decided to
exclude this classification rule from any further tests knowing that it is also
computationally the most expensive one: Testing for optimal parameters has
quadratic complexity compared to the other rules since two parameters have
to be determined at a time. Since we use a diﬀerent approach for parameter
optimization for R3 (compared to R1,R2 and R4) as explained in section 4.2.5,
the diﬀerence in computation time is even more pronounced.
Using the remaining three classification rules, which we will from now on for
simplicity call LR (R1), HR (R2) and LRHR (R3), we consider a total of 24
diﬀerent classifiers: Employing 3 classification rules combined with 4 similarity
measures to gene expression profiles extracted from 2 data sets. These classifiers
are now tested against each other via measuring their performance on LOOCV
and validation on an independent data set.
Let us first focus on the latter performance measurement: Training (i.e.
parameter optimization) is conducted on NEJM176 or Transbig data, keeping
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the respective opposite set for validation. As defined in 4.1 we employe the
following accuracy criterion on the classifiers for training: sensitivity ≥ 0.9 and
specificity as big as possible. This criterion can of course not be used to evaluate
performance on validation sets, since in this case error rates are expected to be
higher than on the training set. On account of this, we define a slightly diﬀerent
criterion to be used as measure of the classifiers performance on a validation
set:
max
param
specificity
s.t. sensitivity ≥ 0.85.
(4.2)
Evaluating the classification performance, we therefore first have a look at the
sensitivity of the classifiers that have been validated on NEJM176 and Transbig
(i.e. trained on Transbig and NEJM176 respectively) and exclude those that
have a sensitivity value of less than 0.85 (figure 4.2). Together we exclude 14 of
the 24 classifiers (11 one the first and 3 on the second validation), because their
sensitivity is less than the given threshold for one of the independent validations
(figure 4.2).
Additionally we perform leave-one-out cross-validation on NEJM176 and
Transbig for all classifiers. For all cross-validations, we observe sensitivity values
higher than 0.85 (in particular higher than 0.8947); thus, we do not exclude any
classifiers based on LOOCV.
The remaining classifiers are compared based on their average specificity
value taken over LOOCV on Transbig and NEJM176 as well as validation on
these data sets after training (for determining optimal parameters) on the re-
spective opposite set (figure 4.3). We would like to point out, that the values are
very similar, if we take the average over the independent validations only (for
details see Appendix D). The classifier using classification rule R3 (LRHR) with
Transbig centroids and Pearson correlation as similarity measure is superior to
the rest with respect to the quality criterion defined above.
Taking a closer look at figures 4.2 and 4.3, we can see that it indeed makes
a substantial diﬀerence which data is used for centroid construction. For the
Nature-centroids (n-centroids) we see a very similar performance for all classifi-
cation rules and similarity measures indicating that the low risk profile provides
as much information as the high risk profile (and as both together), i.e., they
are all (almost) equally suitable for distinguishing low risk samples from high
risk samples. This observation illustrates and endorses the use of just one cen-
troid for the MammaPrint algorithm.7 For the Transbig-centroids (t-centroids)
on the other hand, we observe a very inferior performance when using either
tLR or tHR alone: almost all classifiers being defined on just one of the two
profiles are excluded by the sensitivity-constraint and do also – in general – not
provide high specificity values. Nevertheless, combining both of them within
one classifier (tLRHR) results – when using Pearson correlation as similarity
measure – in the overall best classification. For the n-centroid based classifiers
7Please keep in mind that the nLR profile used here is based on the same samples as the
MammaPrint profile.
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Figure 4.2: Sensitivity values of the 24 tested nearest centroid classifiers on
two validation sets (NEJM176 (a) and Transbig (b)), where training has been
performed on the respective other set. Classifier with sensitivity below 0.85 in
one of the two validations will be excluded for specificity comparison.
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Figure 4.3: Average specificity taken over validation and LOOCV on NEJM176
and Transbig for all 24 tested nearest centroid classifiers. Empty symbols indi-
cate the exclusion of the classifier because of failing the sensitivity constraint in
one of the two validations. The highest specificity value of all classifiers fulfilling
the sensitivity criterion is obtained by t-Pearson-LRHR (0.49).
we observe the same tendency, but less pronounced (e.g. many sensitivity values
of those classifiers that are excluded due to the sensitivity constraint, are still
very close to 0.85). Another interesting observation is, that all classifiers using
cosine correlation as similarity measure are excluded by this constraint.
A ROC curve analysis (see section 2.4.2) further illustrates the inferior per-
formance of the tLR profile on the NEJM (figure 4.4) as well as on the Transbig
data (figure 4.5) which results in a classification hardly better than chance: Av-
eraging the area under the curve, AUC, over each four classifications (employing
diﬀerent similarity measures) results in AUC = 0.58 and AUC = 0.56 compared
to the expected AUC-value 0.5 of a random classifier lying along the diagonal
from (0, 0) to (1, 1). In contrast to this, classification based on the Nature low
risk profile (figures 4.6 and 4.7) is far from being random: AUC is almost 0.7 in
both cases.
The poor performance of the tLR-based classifiers on the Transbig data set
is particularly remarkable as the test data coincides with the data used for
centroid construction, thus low (FN and FP) error rates should be expected.
The same eﬀect, though alleviated, can be observed for classifiers using the
Transbig high risk profile only (figure 4.9). However, also for the ROC analysis
this phenomenon cannot be observed when both profiles are used as centroids
as is shown in figure 4.11.
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Figure 4.4: ROC curve of the tLR
classifiers on the NEJM176 data set.
AUC = 0.5837.
Figure 4.5: ROC curve of the tLR
classifiers on the Transbig data set.
AUC = 0.5631.
Figure 4.6: ROC curve of the nLR
classifiers on the NEJM176 data set.
AUC = 0.6845.
Figure 4.7: ROC curve of the nLR
classifiers on the Transbig data set.
AUC = 0.6899.
Having a closer look at the Transbig profiles, we encountered a strong cor-
relation between the Transbig low and high risk profiles (tLR and tHR): cosine
correlation of 0.6453 and Pearson correlation of 0.693, compared to approx.
−0.0474 and 0.05 for the Nature profiles. This might be an explanation for
the need of both Transbig profiles to eﬀectively classify data: As the centroids
themselfs are very close to each other, i.e., have a high similarity measure, a
sample close to the low risk centroid might also be close to the high risk cen-
troid and we therefore cannot define a meaningful threshold value which allows
to distinguish low risk from high risk samples.
For the n-centroid classifiers there is not such a strong need for two reference
profiles, since the centroids are more distant. This coincides with the observa-
tions made before (figures 4.2 and 4.3). However, considering the ROC curves
in figures 4.10 and 4.8 gives reason to assume that also in this case at least
LR- and HR-centroid classifications that give a sensitivity value around 0.9 are
slightly inferior to those on both profiles.
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Figure 4.8: ROC curve of the nHR
classifiers on the NEJM176 data set.
AUC = 0.6675.
Figure 4.9: ROC curve of the tHR
classifiers on the NEJM176 data set.
AUC = 0.6491.
Figure 4.10: ROC curve of the nLRHR
classifiers on the NEJM176 data set.
AUC = 0.6846.
Figure 4.11: ROC curve of the tLRHR
classifiers on the NEJM176 data set.
AUC = 0.6931.
In contrast to the previous analysis (figures 4.2 and 4.3), a comparison of the
four distance measures gives inconclusive results, as non of the correlation coef-
ficients outperforms any of the others on the basis of ROC curve analysis. This
gives rise to assume that the seemingly inferiority of the cosine-based classifiers
on the evaluation made before can be due to random fluctuations.
We would also like to point out the good performance of the tLRHR clas-
sifiers (figure 4.11) - compared to the others - especially in the area of the
true positive rate (sensitivity) being around 0.9, which is our region of interest,
since we put this value as a sensitivity-constraint for measuring classiifcation
performance.
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4.4 Conclusion
In this test setting, we compared a total of 24 nearest centroid classifiers defined
by: (centroid construction data) x (classification rule) x (similarity measure)
(2 · 3 · 4 = 24). Comparison has been done via performance measurement
(given by sensitivity and specificity) of the classifiers on two diﬀerent data sets:
NEJM176 and Transbig. In order to control the amount of falsely positive
classified samples we applied the quality criteria (4.1) and (4.2) for training and
validation, respectively.
Leave-one-out cross-validation as well as (training and subsequent) valida-
tion on an independent data set and ROC curve analysis have been conducted.
The analyses indicate a superior performance of the classifier defined by Trans-
big centroids using Pearson’s correlation coeﬃcient for similarity measurement
and the gap based classification rule LRHR (R4) (see figure 4.3). In the follow-
ing this classifier will therefore be called best nearest centroid classifier (bNC).
bNC fulfills the optimality criterion constraints of (4.2), i.e., it achieved sensi-
tivity values ≥ 0.85 for both LOOCVs and both independent validations. Fur-
thermore, within the group of 10 classifiers, that comply with the sensitivity
constraint, it provides the highest average specificity value (averaging over the
LOOCVs and the independent validations). Performance details of bNC as
well as optimal gap values obtained by training on the two data sets NEJM176
and Transbig are shown in table 4.48. The optimal gap values obtained dur-
ing training (according to (4.1)) coincide with the respective optimal LOOCV
parameters which are determined via choosing the optimal (training) gap value
that occurred most frequently within all correctly classified left out samples.
Training on NEJM176
Optimal gap-parameter 0.2086
Validation LOOCV
Sensitivity 0.8750 0.8947
Specificity 0.5191 0.5145
Training on Transbig
Optimal gap-parameter 0.2718
Validation LOOCV
Sensitivity 0.9474 0.8958
Specificity 0.4565 0.4723
Table 4.4: Performance (measured by sensitivity and specificity) and optimal
training gap parameters of the t-Pearson-LRHR classifier: bNC. Validation per-
formance is measured on the set not used for training, i.e., on Transbig in the
first case and NEJM176 in the second.
Considering the diﬀerent dimensions, which define our nearest centroid clas-
sifiers, separately we can furthermore observe some general trends:
8More detailed information on the optimal parameters and training and validation perfor-
mances for the remaining classifiers is given in Appendix D.
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similarity measure The comparison of the diﬀerent similarity measures (co-
sine, Pearson, Spearman and Kendall correlation coeﬃcients) reveals only
minor diﬀerences. ROC curve analysis showed that performance curves of
four similar classifiers varying in the similarity measure dimension only are
very close and cross multiple times within the ROC space. The diﬀerent
performances, that we observed on validation sets for varying similarity
measures of a classifier, might therefore be due to random fluctuations.
On the other hand, we also need to keep in mind that although ROC
curves give a more general overview of classifier performances (consider-
ing all possible parameter values at once), they show training performance
only and therefore do not give insight into the performance on ‘unknown’
data sets (validation). Focusing on validation performance on independent
data sets, classifiers using cosine correlation showed to be least stable with
respect to the sensitivity constraint. All six of them that were tested here
fail to reach the constraint value of 0.85 in one of the two validations
(figure 4.2).
classification rule The combined use of two centroids (applying classification
rule LRHR) is generally superior to using just one centroid: Six out of
eight LRHR-classifiers fullfil the sensitivity constraint for all validations
(and cross-validations) compared to only two out of eight LR- and HR-
classifiers, respectively. Furthermore, the average specificity values of the
LRHR-classifiers are always greater than the averaged specificity of the
LR- and HR-classifiers within the group of classifiers varying only by the
classification rule applied (see figure 4.3 and Appendix D). This trend can
be confirmed by the ROC curve analysis performed when focusing on the
area where sensitivity ≈ 0.9. The phenomenon can be observed for both t-
and n-centroids, although it is much more pronounced for the t-centroids
than for the n-centroids.
centroid construction data As we have just seen, there is a huge diﬀerence
between classifiers using t- and n-centroids respectively. These diﬀerences
are mainly reflected by more strongly varying performances within the
t-centroid group when modifying one of the other two dimensions. There-
fore, we do not think, that the diﬀerence in the data size (283 samples
(Transbig) versus 78 samples (Nature)) has a considerable impact on the
classifier’s performances, since in this case we would expect stronger vary-
ing performances within the n-centroid group. However, we would like to
make some remarks on two very important issues that have to be taken
into account:
First, the 70 genes we based our classifications on have been selected in
such a way that they optimize a NC classifier which uses centroids that are
similar to nLR and nHR [60]. In particular, the MammaPrint (LR-) clas-
sifier was found to be equally good as the corresponding LRHR-classifier
(section 4.1). Therefore, it is not surprising that the performances of nLR
classifiers are found to be similar to those of the nLRHR classifiers. For
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the t-centroid classifiers on the other hand, the features selection is inde-
pendent of the Transbig data and we could even see that both centroids
are very similar with respect to the cosine and Pearson correlation coeﬃ-
cient (correlation coeﬃcient ≈ 0.7) while the n-centroids are more distant
(correlation coeﬃcient ≈ 0) (see section 4.3). Those measures have been
used for the selection of the 70 genes.
Second, we would like to point out once more that we used the Trans-
big data set for centroid construction and as part of the learning set,
whereas the n-centroids have been constructed on the Nature data set and
NEJM176 and Transbig do not contain samples of this set. Thus, com-
paring validation performance of t- and n-centroid classifiers on Transbig,
might be biased due to the fact that the t-centroids consist of the aver-
age gene expressions of this data set. However, t-LRHR classifiers also
showed superior performance to n-LRHR classifiers for the validation on
NEJM176 (see Appendix D for details).
Thus, we conclude that declaring bNC the best performing classifier is justified
and focus on this classifier for studying the influence of diﬀerent feature selection
methods on its performance in the following chapter.
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Chapter 5
Feature Selection
In the previous chapter our focus was on the definition of an optimal nearest
centroid classifier based on 70 genes, which were selected during the definition of
MammaPrint in [60]. These 70 genes were chosen out of a set of 231 genes which
had been determined on the basis of their correlation to disease outcome as has
been described in section 3.2.1. By rank ordering of the 231 genes according
to the correlation coeﬃcients a list has been obtained. Classifiers defined on
the top-5, top-10, top-15, . . . genes of this list are then compared with respect
to their performance. This is done by means of leave-one-out cross-validation
which identifies the set of top-70 genes to be optimal for this classifier.
However, as has been shown by Ein-Dor et al [21], correlation-based rankings
of genes strongly depend on the training set chosen and diﬀerences between
correlations are small. They even proved that many sets of 70 genes ranked
between 1 and 770 perform similar to the set of the top-70 genes on the rank list.
A multiple random validation strategy revealed that in fact 5 of 7 classification
methods published do not classify patients better than chance due to strong
dependence of the feature selection on an usually very small set of training data
[41]. Hence, using correlation coeﬃcient rankings does not seem to be the ideal
way of addressing the problem of feature selection for the classification of tumor
outcome.
In this chapter we are going to investigate diﬀerent feature selection methods
that have been introduced in section 3.2. This is done by measuring bNC’s
accuracy when the feature sets selected by those methods are considered as the
basis for classification. We view this classifier as a class of classifiers, meaning
that we do not pre-specify its optimal gap-parameter, since the two previous
choices (0.21 and 0.28 as explained in the chapter 4) have been obtained by
training on the set of 70 preselected features.
In the following we would ideally like to start with a set of non-preselected
genes. Unfortunately, for most sample data we do not have access to the full
genome since it has been measured on user-specific microarrays that only con-
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sider the set of 231 (plus some normalization) genes.1 These genes are measured
in (2 times)2 triplicate on the LD8pack array and in quintuple on the 44k array.
Hence we can benefit from the fact that very little measurement noise can be
expected. Since it is also computationally much more eﬃcient to work on a
smaller set of genes that one can select from, we will in the beginning restrict
ourselves to this set of 231 genes knowing that results might be biased due to
the preselection step. Thereafter, we will give an outlook of how those methods
work when considering a larger base set than just the 231 genes.
Consider now just this set of 231 features, from which we want to select an
optimal subset (using diﬀerent feature selection methods), such that bNC’s per-
formance is ‘best’ on this subset. In order to do so, we apply the same training
and validation technique (for the Transbig and NEJM1763 data sets) as used
in chapter 4, except for the fact that we conduct only one training/validation
(and no LOOCV). Thereby we obtain one optimal feature set for each feature
selection method. The performance of bNC on these subsets is then compared
on a third independent data set (LNpos).
The reasons why we decided to use only one validation measurement for
determining the respective optimal feature sets are, that first it is more eﬃcient
and second the combination of training on Transbig and validation on NEJM176
is the most powerful prediction of classification accuracy: since bNC is defined
on two Transbig centroids4, we only want to measure its performance on the
independent set NEJM176.
For the (gap) parameter optimization which is done during training for each
set of features, we apply the same optimality criteria as defined before in (4.1):
max
param
specificity
s.t. sensitivity ≥ 0.9
for training and with a lower sensitivity constraint of 0.85 for validation (4.2).
Three of the four following feature selection methods are used to extract a
list of subsets of genes G = [G1, . . . , GT ] that serves as input to a sequential
forward selection algorithm (SFS):
For each feature set Gt, t = 1, . . . , T we train bNC on Transbig (using only
the features contained in Gt) and subsequently measure its performance on
NEJM176.5 The set with optimal validation performance according to the op-
timality criterion defined in (4.2) is chosen as the set of selected features.
1See section 2.1 for details regarding the diﬀerent the microarrays.
2One normal and one dye-swap measurement.
3Please note that here again, we do not want to incorporate the Nature samples into the
NEJM data set, since the 231 genes have been selected on their basis and we do not know
what eﬀects that would have on performance measurements.
4We constructed centroids of the Transbig data on the set of 231 genes in the same way as
described before in chapter 4.
5If the set contains less than two features, no classification can be conducted, since at least
two distinct values are needed for the calculation of the Pearson correlation. The performance
measurements are then set to zero.
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In sections 5.1 - 5.4 we select features based on each of the feature selection
methods defined in section 3.2:6 nearest shrunken centroid (NSC), AdaBoost
feature selection (AdaBoost),7 the adaptive Lasso (Lasso) and the adaptive
Lasso for Cox’s model (LassoCox). These methods are then (in section 5.5)
compared against each other by measuring the performance of bNC using the
selected feature sets, on a third data set (LNpos), that has not been used so far.
Thereafter, in section 5.6 we give an outlook on how these procedures influence
the performance of nearest centroid classification when features are selected
from a larger set of features than only the one consisting of the preselected 231
genes.
5.1 Nearest Shrunken Centroid
As defined in section 3.2.2, the nearest shrunken centroid method is designed
to shrink the class centroids to the overall centroid in order to filter for those
features whose average expression values diﬀer most in both classes, i.e., those
that diﬀer most from the overall centroid in at least on class. For our binary
classification problem we thus consider the low and the high risk profiles as
centroids x¯0 and x¯1,8 respectively, whose components are to be shrunken to the
overall centroid (x¯i)i = (
￿n
j=1
xij
n )i. This is done by shrinkage of
9
di0 =
x¯i0 − x¯i
m0 · si and di1 =
x¯i1 − x¯i
m1 · si
for each gene i = 1, . . . ,m by ∆ towards zero:
d￿i0 = sign(di0)(|di0|−∆)+ and d￿i1 = sign(di1)(|di1|−∆)+
and thereby shrinking the class centroids towards the overall centroid:
x¯￿i0 = x¯i +m0 · si · d￿i0 and x¯￿i1 = x¯i +m1 · si · d￿i1.
If both di0 and di1 are smaller than ∆, it follows that d￿i0 = d￿i1 = 0 and therefore
x¯￿i0 = x¯￿i1 = x¯￿i. Hence, gene i does not contribute to the classification rule any
more since a sample’s distance to both centroids at index i is necessarily the
same. The bigger ∆ is chosen, the less genes contribute to classification. The
optimal value for ∆ is usually chosen by measuring performance of the classifier
defined by the classification rule given in (3.6).
6Except for feature selection by correlation, which has been used to determine the set of
231 genes we start with
7For AdaBoost it is not necessary to use an additional SFS algorithm, because this method
provides the possibility to directly incorporate the performance of a given learning classifier
into this embedded method (see section 5.2).
8For convenience we use class indices 0 and 1 representing the negative and the positive
class instead of 1 and 2, respectively.
9See section 3.2.2 for definitions of the variables m and s
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In order to adapt this method to the specific problem of controlling sensi-
tivity as has been explained in chapter 2, we will use the idea of the previously
described algorithm modifying the last step of choosing the optimal parameter
∆: we do not measure the performance of the NSC classifier defined by (3.6),
but the performance of bNC on the validation set NEJM176 after training on
Transbig.
Therefore, we conducted the following steps: First we use the ‘pam’ program
[4], which embeds the R-code [45] for the NSC algorithm in Excel, to extracted
a list of genes G￿. Second we use this list as an input to the SFS-algorithm
described above and thereby determine the optimal set of features.
G￿ = [g1, . . . , g231] is obtained by setting ∆ = 0 and thereby ordering the
231 genes by their distances to the overall centroid, i.e., by ordering of the set
{max(|x¯i−x¯i0|, |x¯i−x¯i1|) | i = 1, . . . ,m} . This order corresponds to the inverse
order in which they would be shrunken to the overall centroid since genes with
larger distances are shrunken to the overall centroid only for bigger values of ∆.
Thus, taking the first k elements of this list translates to implicitly choosing ∆
such that the elements k + 1, . . . ,m of the class centroids are shrunken to the
overall centroid.10 Figure 5.1 shows the cross-validation error depending on the
number of genes selected. Varying values of ∆ (leading to diﬀerent numbers of
selected features) are plotted against the misclassification error (see definition
4) of NSC. The diﬀerences in the individual and the overall misclassification
errors are due to the fact that the true positive class is far smaller than the true
negative class (38 versus 138 samples). Nevertheless, it is surprising that for
large values of ∆, NSC classifies all samples negative (misclassification error is
1 for the positive and 0 for the negative class), which might be caused by the
preselection of the 231 genes. However, this again emphasizes the need for a
diﬀerent evaluation method for choosing the optimal value of ∆.
Hence, we extract a list G = [G1, . . . , G231], where Gt = {g1, . . . , gt} for
gl ∈ G￿, l = 1, . . . , t and t = 1, . . . , 231. This list is then taken as an input
to the sequential forward selection algorithm, where we measure performance
(on the NEJM176 validation set) for each subset of features starting with 2
(G2) up to the full set of 231(G231) features (results are shown in figure 5.2).
Validation performance is depicted by the solid line, training performance by
the dashed line, where we measure sensitivity (red ‘upper’ lines) and specificity
(green ‘lower’ lines) in both cases. The maximum validation specificity of 56%
(of those classifications fulfilling the sensitivity constraint of 0.85) is reached at
a set of 37 features. We conjuncture that further increasing the feature set size
does not provide any new information for bNC’s classification since we cannot
obtain any improvement of its accuracy and furthermore results remain very
stable form this point on (indicating that all valuable information is already
present in the set of 37).
10This implies that these elements do not contribute to classification.
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Figure 5.1: Threshold = ∆ (and the corresponding number of selected features
(top)) is plotted against the 10-fold cross-validation error of NSC on the whole
data set (with confidence intervals) in (a) and for the individual groups positive
(1) and negative (0) in (b).
5.2 AdaBoost Feature Selection
We adopt the approach of using the AdaBoost algorithm for feature selection
introduced in [14]. This method requires a weak learner as well as a learning
classifier, where the latter is used for performance measurement in the boost-
ing algorithm. Since we can choose bNC as the learning classifier our quality
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Figure 5.2: Training and validation performance of bNC depending on the num-
ber of features selected form the list obtained by the nearest shrunken centroid
algorithm. Optimal validation performance is obtained for 37 features.
measurement (4.2) can directly be incorporated into this embedded method.
Therefore, we do not need to use it for the extraction of a list of genes that
serves as an input to our sequential forward selection algorithm, but use the
method as a stand alone feature selection procedure.
We apply (a modified version of) the AdaBoost algorithm (algorithm 1 in
section 3.1.6), where in each boosting iteration step t = 1, . . . , T a decision
stump is used as weak learner on the learning set L = (X, y) given a distribution
Dt. This tree stump selects from the set of currently non-selected features a
gene i such that the corresponding optimal classification rule Ci maximizes the
information gain (see section 3.2.3), i.e., minimizes the conditional entropy
H(L | Ci) = pDt(Ci(X) = −1) ·H(L | Ci(X) = −1)
pDt(Ci(X) = +1) ·H(L | Ci(X) = +1).
The probability estimate pDt is given by pDt(Ci(X) = k) =
￿
{j|Ci(xj)=k}Dt(j)
and Ci is defined (up to changes of signs) by
Ci(xj) =
￿ −1 if xij < x˜i
+1 else
for some optimal threshold value x˜i.
To obtain the weak hypothesis we modify the AdaBoost algorithm according
to [14], in that we use the classification result of the learning classifier (bNC)
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instead of the classification result of the weak learner (the decision stump).
bNC’s weak hypothesis is the outcome of the training on Transbig, i.e., the
training performance, where sensitivity is guaranteed to be at least 0.9. On the
basis of this the new distribution Dt+1 is calculated which serves as an input to
the weak learner for selecting the next feature in step t+ 1.
The optimal features set is (as in SFS) determined by the performance mea-
surement on the validation set NEJM176. Results depending on the boosting
iteration steps are shown in figure 5.3, where the optimal performance (speci-
ficity of 56%) is found at a set containing 129 features. Here we can clearly
Figure 5.3: Training and validation performance of bNC depending on the num-
ber of features selected by the AdaBoost feature selection method. Optimal
validation performance is obtained for 129 features.
see poor validation sensitivity measurements up to approximately 50 selected
features. Thereafter, specificity fluctuates a lot until the optimal feature set
is found and performance stabilizes (around 52% for specificity and 85% for
sensitivity). Compared to NSC, a larger set of features is needed to attain the
optimal performance, which is very similar to the performance of the optimal
NSC set of 37 features.
5.3 The Adaptive Lasso for Feature Selection
Recall the definition of the adaptive Lasso algorithm given in section 3.2.4:
Let X ∈ Rm×n be a standardized data matrix for n samples and m genes
(
￿
j xij
n = 0,
￿
j x
2
ij
n = 1, i = 1, . . . ,m) and y ∈ Rm the corresponding centered
class outcome vector (y¯ = 0), where the class observations are assumed to be
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independent or conditionally independent given X. Let λ ≥ 0 be a scalar and
w ∈ Rm a vector of weights. Then the adaptive Lasso estimate βˆ ∈ Rm is given
by (3.8):
βˆ = argminβ
n￿
j=1
￿
yj −
m￿
i=1
βixij
￿2
+ λ
m￿
i=1
wi|βi|.
In order to solve this minimization problem, we will use the algorithm pro-
posed by Zou in 2006 [65]. It defines the weight vector as the inverse of a power
of the ordinary least square estimate βˆ0:
w =
1
|βˆ0|γ
for some γ ≥ 0. As their paper lacks an explanation on how to choose γ, we
followed their example and simply set γ = 1. To solve (3.8) we implemented
algorithm 2 which makes use of the Lars algorithm [19].
Algorithm 2 The Lars algorithm for the adaptive Lasso
1. Define x∗i =
xi
wi
, i = 1, . . . ,m, where xi = (xi1, . . . , xin).
2. Solve the Lasso problem
βˆ∗ = argminβ
n￿
j=1
￿
yj −
m￿
i=1
βix
∗
ij
￿2
+ λ
m￿
i=1
|βi|.
for all λ.
3. Compute βˆi = βˆ
∗
i
wi
, i = 1, . . . ,m.
For the implementation of this algorithm in Matlab [53], we used the stan-
dard lscov algorithm to solve the ordinary least square problem. Since this
algorithm cannot deal with values that are ‘not a number’ (NaN), we used the
standard knnimpute command for replacing NaN-entries with the corresponding
entry of the nearest column in euclidean distance (with the entry of the samples
that is closest to the one with the missing number). The solution of lscov is
then used to define w and hence x∗, where the latter together with the outcome
vector y is given as an input to the Lars package [51], which solve the Lasso
problem of step two. This package can solve the problem for all possible values
of λ, λ(1), . . . ,λ(T ), that correspond to the solutions βˆ∗(1), . . . , βˆ∗(T ). At each
iteration step t = 1, . . . , T a feature is either added or deleted from the set of
currently selected features. A feature i is delete if the element βˆ∗(t)i of the Lasso
estimate is set to 0 for βˆ∗(t−1)i ￿= 0 and added if βˆ∗(t)i ￿= 0 for βˆ∗(t−1)i = 0.
Since we are not interested in the weighting of the features i = 1, . . . ,m, we
omit the last step and take the list of features G = [βˆ∗(1), . . . , βˆ∗(T )] as an input
to our sequential forward selection algorithm (results shown in figure 5.4).
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Figure 5.4: Training and validation performance of bNC depending on the iter-
ation steps of the adaptive Lasso algorithm. Optimal validation performance is
obtained for 133 features.
For this approach we observe poor performance (with respect to validation
sensitivity) up to iteration point 150 where the optimal set of 133 features is
found. The validation specificity at this point is 57%, which for further iterations
rapidly declines to values slightly above 50%.
5.4 The Adaptive Lasso for Feature Selection in
the Cox Model
The last feature selection algorithm we consider in this study is the only one
that is not based on the usual data input X and y, a sample data matrix and
the corresponding binary outcome vector, that is defined by the clinical outcome
(of metastasis development) within 5 years. The Cox model takes into account
continuos measurements of metastasis development: the input is given by the
triple (s,X, δ), where s is called the survival vector, which for each patient j
contains the exact time span sj of either the detection of disease development
or the end of the follow-up time. Hence, we do not restrict ourselves to one
particular point in time (5 years after diagnosis) where we look at disease de-
velopment, but incorporate more detailed information into the feature selection
algorithm. This method therefore provides a more flexible adaptation to the
input data X than the before mentioned ones, since it does not depend on an
arbitrary definition of class labels [25, 29]. Consider for example two patients,
one developing metastasis after 5 years and one day and the other one never de-
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veloping distant metastasis. In the previous settings the true outcome class for
both patients is the same. Now, the Cox model can account for the diﬀerences
within each of the two possible outcome classes. Since it might not be known
for all patients when (if at all) they developed metastases, the binary censoring
vector δ is introduced, which for each patient j encodes whether sj is the time
of the detection of disease development or the end of the follow-up time. In
other words, δj = 0 indicates that patient j developed distance metastases after
time sj and δj = 1 indicates that he did not develop metastases up to time sj .
Since in the later case the follow-up ended at time sj (after diagnosis), we do
not know whether the patient developed metastases after that point in time (i.e.
the data is censored).
For failure times t1 < · · · < tk (corresponding to the elements of the set
{sj | dj = 0, j = 1, . . . , n} when ordered in ascending order) the adaptive Lasso
estimate for Cox’s model is given by (3.10):
βˆ = argminβ − ln (L(β)) + λ
m￿
i=1
wi|βi|,
where L(β) is the partial likelihood of the hazard h(t | X) at time t estimating
the survival rates of the patients at risk starting from time t (see section 3.2.5):
h(t | X) = h0(t)eβTX .
Algorithm 3 The Lars algorithm for the adaptive lasso in Cox’s model
1. Calculate the estimate βC = maxβ ln(L(β)) and the Hessian I(βC) of the
log partial likelihood.
2. Obtain the (Cholesky) decomposition I(βC) = V TV .
3. Compute u = V βC and carry out the transformation v∗i = vi|βCi | for the
rows vi, i = 1, . . . ,m of V .
4. Solve the Lasso problem
βˆ∗ = argminβ
n￿
j=1
￿
uj −
m￿
i=1
βiv
∗
ij
￿2
+ λ
m￿
i=1
|βi|.
for all λ.
5. Compute βˆi = βˆ
∗
i
wi
, i = 1, . . . ,m, where wi = 1|βCi | , i = 1, . . . ,m.
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As suggested in [66], we calculated the vector of weights w by maximization11
of the log partial likelihood
ln(L(β)) =
￿
{j|δj=1}
βTxj − ln
￿
n￿
l=1
eτjβ
T xl
￿
,
where τj = (τj1, . . . , τjn) is defined by τjl = sl≥sj , l, j = 1, . . . , n.
However, we did not follow the approach of [66] any further since we were
confronted with problems in the convergence of the proposed modified shooting
algorithm that we could not solve. Therefore, we decided to implement algo-
rithm 3 proposed by Zou [64], where in step 1 the inverse weight vector βˆC is
calculated according to [66]. Again we omit the last step and take the list of fea-
tures βˆ∗(1), . . . , βˆ∗(T ) returned by the Lars package in step 4 as an input to our
sequential forward selection algorithm. Results are shown in figure 5.5, where
the optimal performance is determined at iteration step 539, for 229 features.
Figure 5.5: Training and validation performance of bNC depending on the it-
eration steps of the adaptive Lasso algorithm for the Cox model (proportional
hazard model). Optimal validation performance is obtained for 229 features.
However, we can see that the performance curve is very stable already before
this iteration step and the increase in performance could be an ‘outlier’ result.
Therefore, we also depicted the second best performance measurement obtained
at iteration step 263 for a set of 171 features. Clearly, from that point on we
observe only minor changes in the validation specificity, similar to the observa-
tions we made before for the other feature selection methods. Therefore, we will
11We used the standard Matlab routine fminunc with the Simplex algorithm for optimiza-
tion. Here again, knnimpute was applied to the data matrix when necessary.
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for this method not only consider the optimal feature set of 229 features (valida-
tion specificity 56%), but also the second optimal set of 171 features (validation
specificity 55%).
5.5 Comparison of Feature Selection Methods
Looking at the performance development as the number of selected features
increases, we can generally observe a similar pattern for all feature selection
methods:
Each curve starts at 0 indicating that we cannot perform classification (at least
2 distinct values are needed for the calculation of the Pearson correlation coef-
ficient). Then performance increases very fast suggesting that each additional
feature adds a lot of information and that using a set of very few features does
not suﬃce for the prediction of distant metastasis development. This charac-
teristic is followed by an interval, where training performance is quite good,
but validation yields very unstable results until it peaks at the optimal feature
set and thereafter becomes very stable for both training and validation perfor-
mances. Please note, that only for feature selection via NSC and AdaBoost the
number of features coincides with the number of iterations on the x-axis. For
the Lasso methods, in each iteration either a feature is deleted or added and
the size of the feature set is therefore not (strictly) monotonically increasing.
However, since the number of selected features increases over time (given by the
iteration steps) from 2 to the full set of 231, we can still consider a general trend
of increase in the size of the selected feature subsets.
classifier NSC AdaBoost Lasso LassoCox2 LassoCox
no of features 37 129 133 171 229
gap value 0.3603 0.2357 0.1791 0.2313 0.2032
train. sensitivity 0.9167 0.9167 0.9375 0.9167 0.9167
train. specificity 0.5574 0.5660 0.5872 0.5660 0.5745
valid. sensitivity 0.8947 0.8684 0.8684 0.8684 0.8684
valid. specificity 0.5580 0.5580 0.5725 0.5507 0.5580
Table 5.1: Optimal number of features as well as optimal gap parameter and
training and validation performance of bNC on the feature sets determine by
diﬀerent feature selection methods. LassoCox2 denotes the second best feature
set for the adaptive Lasso for Cox’s model.
Consider now the best performing classifiers on the respective optimal fea-
ture sets in some more detail. Table 5.1 shows their training performances on
Transbig and validation performances on NEJM176 as well as their optimal
(training) gap values and the number of features forming the sets of selected
features. The validation performance measurement is used to determine the
optimal feature subsets. Clearly, the optimal validation specificity values are
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very similar for all tests: between 55% (LassoCox2) and 57% (Lasso). However,
as NEJM176 was part of the learning procedure (since it is used for choosing
the optimal feature sets) we do not want to compare these five classifiers by
their performance on this set. Therefore, we measure their performance on the
independent12 LNpos data set which has not been used before in this analysis
(see figure 5.6). The LNpos set consists of samples where the patients are lymph
Figure 5.6: Comparison of bNC classification depending on the feature sets used
for training (on Transbig). ‘MP (70)’ denotes the feature set of 70 features on
which MammaPrint was developed and which was the basis for choosing bNC
in the previous chapter. ‘all (231)’ denotes the bNC classifier trained on all 231
features.
node positive for 1 to 3 lymph nodes, i.e., there was a metastasis found in 1 to 3
regional lymph nodes.13 In contrast to this, the data sets we used so far contain
only lymph node negative samples (without any metastases). However, this is
still in the scope of samples (defined in chapter 1) that have maximal three
positive lymph nodes. The LNpos data sets consists of a total of 226 samples,
32 of them being high risk and 194 low risk samples.
All five classifiers are bNC classifiers that diﬀer by their gap parameter
values, which are given in table 5.1 and were determined by training on Transbig.
Additionally, we also consider bNC trained on Transbig for the full set of 231
genes, because we are interested in the diﬀerence of this classifier to the one
trained on the LassoCox feature set of 229 genes, i.e., a feature set where only
2 of the 231 genes were excluded for classification. Surprisingly, the diﬀerence
in performance between those two sets is remarkable high (specificity increases
12Independent of both data sets Transbig and NEJM176 used during learning.
13Lymph nodes adjacent to the primary tumor. See section 2.3 for details.
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by almost 6% from 54.6% for the set of 231 genes to 60.3% for the set of 229
genes, while sensitivity remains the same (96.9%)). Generally, the performance
of the original bNC classifier on the set of 70 genes can be improved by 3 - 11
percentage points, i.e., by 6 - 22% depending on the feature selection method
used.
The overall best performance is achieved when using the set of 229 features
determined by the adaptive Lasso feature selection method for Cox’s model.
Even the performance on the Lasso feature set, which showed the most promising
results on NEJM176, is inferior to this set.
However, we also see that the performance on the whole set of 231 genes is
superior to the one on the 70 selected features and the AdaBoost features and
equal to the one after feature selection by NSC. The biggest improvement from
no selection (taking all 231 genes) is given by the feature set selected by Lasso-
Cox, which is almost identical to the full set, disregarding only two genes. One
possible conclusion of this surprising result is, that these 2 genes only introduce
noise into classification. The good result when using the preselected set of 231
genes might indicate that it already has a good predictive power and most of
the genes are actually needed for the classification of breast cancer outcome.
Other explanations are that either the feature selection methods studied here
are not as powerful as expected (and therefore comparable to the correlation
based selection) or the set of 231 is too small for a basis set and furthermore
strongly biased due to the preselection.
In order to get some more insight into the diﬀerences between the feature
selection methods that give distinctive results regarding the optimal number of
selected features, we have a brief look at the overlap of the optimal feature sets
in table 5.5. Similar to the results shown in [21], the feature sets obtained in
this study also have very little overlap, in that the observed overlap is very close
to the expected number of overlapping features when choosing randomly from
a hypergeometric distribution with 231 features.14
Only when comparing the overlap of AdaBoost and NSC or AdaBoost and
the 70 features of MammaPrint, respectively, we can see a considerable diﬀer-
ence in the observed and expected number of overlapping features. A possible
interpretation of this little overlap is, that indeed (as stated in [21]) there is no
unique set that is optimal for the prediction of distant metastasis development
in breast cancer tumors. On the other hand, here again, we must take into
account that the basic set of 231 features we considered is relatively small and
preselected by the correlation of their gene expression (in the Nature data) to
the disease outcome (see section 3.2.1).
14The random overlap between two subsets A and B of the 231 genes is calculated by the
expected number of elements in B that are chosen, when randomly drawing |A| elements from
the 231 genes.
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(a) Observed overlap
MP NSC AdaBoost Lasso L-Cox2 L-Cox
MP 70 11 20 38 49 69
NSC 37 27 22 28 37
AdaBoost 129 79 94 128
Lasso 133 95 132
L-Cox2 171 169
L-Cox 229
(b) Expected Overlap
MP NSC AdaBoost Lasso L-Cox2 L-Cox
MP - 11.21(2.57)
39.09
(3.48)
40.3
(3.46)
51.82
(3.07)
69.39
(0.65)
NSC - 20.66(2.77)
21.3
(2.76)
27.39
(2.45)
36.68
(0.52)
AdaBoost - 74.27(3.74)
95.49
(3.32)
127.88
(0.7)
Lasso - 98.45(3.3)
131.85
(0.7)
L-Cox2 - 169.52(0.62)
Table 5.2: The observed overlap of feature sets selected by the diﬀerent fea-
ture selection methods (a) and the expected overlap (and standard deviation
in brackets) assuming that the features are randomly chosen according to a
hypergeometric distribution (b).
5.6 Feature Selection on a Larger Set of Features
In order to get an idea of how the aforementioned feature selection procedures
work when considering a larger set of features to select from, we would like to
redo the analysis described before on a new enlarged set of genes. However, we
cannot conduct the exact same analysis as presented before, since we have little
data of the full genome: of the three data sets, Transbig, NEJM176 and LNpos,
only NEJM176 is measured on the 44k array, which measures the full genome.
However, if we considered the full genome of approximately 25,000 genes,
the analysis would not be very eﬃcient and furthermore a lot of noise would be
introduced by genes that do not influence tumor behavior. One possibility of
addressing this problem is preselecting genes by a test for diﬀerentially expres-
sion [17]. We did not have to do that, because for this study we were provided
with an already preselected set of 2577 genes that are used for various cancer
tests.
With the base set of 2577 genes and the NEJM176 data set15 we now analyze
15Please note, that here the Nature samples could be included into the analysis, but we
still do not know, how this would aﬀect the performance measurements, since the set of 2577
genes contains the 231 genes that have been selected during the Nature study.
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the feature selection methods NSC, AdaBoost and Lasso again. The LassoCox
procedure is not included here, since we encountered numerical problems: First,
the calculation of the estimate βC in step 1 of algorithm 3 results in values to
be ‘not a number’ (‘NaN’) or ‘infinity’ (‘inf’) for standard Matlab optimization
algorithms. Second, even if we exchange this step by a diﬀerent approach (e.g.
choose βC = (1, . . . , 1) which defines the (nonadpative) Lasso), we are still
confronted with a very slow calculation of the Hessian matrix and numerical
instabilities in the Lars algorithm. Hence, we focus on the remaining three
algorithms only and conduct a similar analysis as before:
Since the Transbig data is not available on the full genome, we calculate low
risk and high risk gene expression profiles form NEJM176 that are used as
centroids. Thus, we cannot construct a version of bNC any more, but define
a new nearest centroid classifier, bNC2, as the classifier using the NEJM176
centroids, Pearson correlation as similarity measure and the same classification
rule (LRHR) as bNC. On account of the limited number of samples provided by
NEJM176, we also decided not to split the data into a training and a validation
set, but use 5-fold cross-validation instead for determining the optimal feature
set. The performance of the diﬀerent feature selection methods as a function
of the iteration steps are shown in figure 5.7. The performance curves are only
shown up to maximum of 350 iteration steps, because all optimal feature sets
are found within this range. Furthermore, the Lars package used within the
adaptive Lasso feature selection algorithm, restricts the number of iterations to
less than 350 and therefore, no data is available for the subsequent iterations.16
Full performance curves for NSC and AdaBoost can be found in figures D.1 and
D.2 in the appendix.
Generally, when compared to the previous results a higher average perfor-
mance (specificity ≥ 0.6 and sensitivity ≈ 0.85) can be observed for the first
350 iteration steps. This might of course be a bit overoptimistic, since cross-
validation instead of an independent validation measurement is used. Therefore,
it is not possible to draw a direct comparison between the two analyses, since
the cross-validation is not independent of training. This should be kept in mind
for the interpretation of the results in the following part.
Using NSC an optimal set of 32 features is selected, where specificity is
67%. Further increasing the number of features does not yield any improvement
and the specificity value remains very stable for increasing numbers of selected
features. It is remarkable, that compared to the previous analysis approximately
the same number of features (37 versus 32) form the optimal feature sets and
nevertheless, the overlap between the two sets is zero. The performance of
the validation on NEJM176 (after training on Transbig) in the previous test
setting compared to the cross-validation performance on the same set here, is
12% higher in specificity.
For the feature selection via the (modified) AdaBoost algorithm, this diﬀer-
ence is even more pronounced: The optimal feature set (of 124 features) selected
16When forcing the increase of the number of iterations in the Lars algorithm, we encoun-
tered numerical instabilities during matrix inversions.
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Figure 5.7: Training and validation performance of bNC depending on the it-
eration steps for the NSC, AdaBoost and the adaptive Lasso feature selection
methods, respectively. Optimal validation performance is obtained for sets of
32 (NSC), 134 (AdaBoost) and 143 (Lasso) features, respectively.
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via cross-validation showed 86% specificity, whereas previously the (indepen-
dent) validation specificity on NEJM176 was only 53% (33% less). Interestingly,
here we cannot see a clear ‘peak’ in the cross-validation performance curve, but
rather an interval between iteration steps 70 and 170, where specificity is con-
stantly very high and thereafter decreases (until the maximum iteration step
2577 as can be seen in figure D.2 in the appendix).
Again the feature selection via the adaptive Lasso, selects for the largest op-
timal features set (of the three methods compared here) of 143 features, where
specificity is found to be 73%. Generally, the performance curve fluctuates more
than for the other two feature selection methods, which might be due to the
fact, that the number of features does not increase with each iteration step.
However, after the specificity reaches its optimum, the specificity curve seems
to stabilize around 65%.
classifier NSC AdaBoost Lasso
no of features 32 124 143
gap value 0.2042 0.0034 0.0120
training sensitivity 0.9211 0.9211 0.9211
training specificity 0.6522 0.8623 0.6884
cross-validation sensitivity 0.8684 0.8947 0.8684
cross-validation specificity 0.6739 0.8623 0.7319
Table 5.3: Optimal number of features as well as optimal gap parameter and
training and validation performance of bNC2 on the feature sets determined by
diﬀerent feature selection methods applied to the set of 2577 genes.
Table 5.3 summarizes the performance measurements of the bNC2 classifiers
on the optimal feature sets obtained by the respective feature selection method.
Training and cross-validation performance on NEJM176 as well as the optimal
gap parameter values (of the training) are shown.
The superiority of bNC2 on the feature set selected by the AdaBoost feature
selection algorithm is remarkable. Here, both sensitivity and specificity are
found to lie between 85% and 90% for the cross-validation measurement. This
also explains, why the optimal gap value in this case is close to 0: if the training
performance can achieve an accuracy of around 90% for both patient groups, the
constraint sensitivity ≥ 0.9 causes only a small shift of the gap parameter value.
If on the other hand sensitivity and specificity range around for example 70% for
the classical nearest centroid classification (gap = 0), then the gap parameter
value has to be increased, i.e., more samples should be classified high risk, in
order to achieve a higher sensitivity (at the expense of decreasing specificity).
Table 5.6 shows that also for this analysis, the overlap of the diﬀerent optimal
feature sets is very low. This also holds true for the comparison of the two
feature sets determined by the same feature selection method, but on diﬀerent
basic sets of 231 and 2577 features, respectively. The only exception is the
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on 2577 features
NSC AdaBoost Lasso
on 2577 features
NSC 32 3 (1.54) 2 (1.78)
AdaBoost 124 56 (6.88)
Lasso 143
on 231 features
all 2 (2.87) 7 (11.12) 13 (12.82)
NSC 0 (0.46) - -
AdaBoost 4 (6.21) -
Lasso 3 (7.38)
Table 5.4: The observed overlap of feature sets selected by the diﬀerent fea-
ture selection methods on the base set of 2577 features. The expected overlap
according to a hypergeometric distribution is given in parenthesis.
overlap between the feature sets selected by AdaBoost and Lasso. They show
an overlap of 56 genes, where only 6.88 would be expected by randomly choosing
features (standard deviation is 2.49). It is especially remarkable that most of
the overlapping features are selection in the beginning of the AdaBoost iteration
steps, e.g. 19 of the first 30 features are also selected by the adaptive Lasso and
in particular all 56 overlapping genes are chosen within the first 111 boosting
iteration steps.
Consider now the overlap of the genes selected by the feature selection pro-
cedures (on the larger base set of 2577 genes) to the set of 231 genes, that
were considered as a base set before. Here, the number of overlaps is also not
very diﬀerent form what would be expected by change. This again confirms our
assumption that this preselected set is not suitable for performing meaningful
feature selection. Furthermore, it oﬀers an explanation for the huge diﬀerence
in performance of the AdaBoost feature selection: Although it showed the worst
results before, it now clearly outperforms the other two feature selection proce-
dures selecting only 7 of the 231 genes.
These results hint at the conclusion that the AdaBoost and adaptive Lasso
feature selection methods might be superior to NSC and truly select genes that
have high predictive values (alone and especially in conjunction with the rest
of the selected features). The characteristics of the diﬀerent feature selection
methods support this assumption: NSC does not evaluate the predictive power
of the conjunction of features, but chooses those that are farthest from the over-
all centroid. This method might also suﬀer from the unbalanced data sets we
used: The low risk group is considerably bigger than the high risk group and
thus the former influences the elements of the overall centroid more than the
latter. AdaBoost and the adaptive Lasso on the other hand are able to adapt
the selection process to the intermediate evaluation of the set of selected fea-
tures. The adaptive Lasso tries to minimizes a regression function and implicitly
adds or deletes a feature of the set of currently selected features by modifying
the value of λ. The AdaBoost feature selection algorithm even incorporates the
classification result of the learning classifier (bNC or bNC2, respectively) on
the set of selected features for the selection of the next feature. Since (repeat-
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edly) misclassified samples are weighted higher than correctly classified ones, the
algorithm will eventually select those features that support the correct classifi-
cation of those repeatedly misclassified outlier samples. Thereby the predictive
power of the set of selected features is increased probably more than by adding
a feature that has only a high predictive value on its own.
5.7 Conclusion
In this chapter we focused on the analysis and comparison of diﬀerent feature
selection methods: the nearest shrunken centroid (NSC) [56], the AdaBoost
algorithm for feature selection [14], the adaptive Lasso [65] and the adaptive
Lasso for Cox’s model [64]. This has been done by investigating the influence
of these feature selection methods on the nearest centroid classifier bNC, which
showed to be the best performing classifier in the analysis of chapter 4.
Most data sets that are available to us, contain only measurements of a small
subset of 231 genes, that were selected during the development of MammaPrint
[60]. We therefore decided to conduct a first analysis of feature selection methods
taking those 231 genes as a basis set to select from. For performance measure-
ment, we decided to use Transbig as a training and NEJM176 as a validation
data set and apply the same quality criteria as before (defined in equations 4.1
and 4.2). Since we want to compare the feature selection methods by means
of their influence on the performance of bNC, we defined a simply sequential
forward selection algorithm (SFS). It takes as input a list of subsets of genes
generated by a feature selection procedure and evaluates bNC’s performance for
each of those subsets on NEJM176 after training on Transbig. The one with best
validation performance, is considered optimal. NSC and the two Lasso feature
selection approaches are used in combination with SFS, whereas the AdaBoost
feature selection works as a stand-alone method, that uses bNC as a so called
learning classifier.
The resulting nearest centroid classifiers (defined on the respective selected
feature sets) are then compared against each other and against the classifier
defined on the 70 genes used in chapter 4. This is done by measuring their per-
formance on a third, independent data set (LNpos), that is not used during the
learning procedure. All feature selection methods provide bNC with a feature
set, that leads to an increase in specificity by 6 - 22% compared to the original
set of 70 genes. However, only minor diﬀerences between the performances on
the respective sets of selected features can be observed. Surprisingly, the whole
set of 231 genes provides bNC with a feature set exactly as good as the one
selected by NSC and even better than the one selected by AdaBoost. The best
feature set in this analysis consists of 229 genes (nearly all of the 231), that are
selected by the adaptive Lasso for Cox’s model.
In order to get an idea of how those feature selection methods influence
nearest centroid classification when considering a larger base set of features,
we conducted a second analysis on an enlarged set of 2577 genes that are used
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for various cancer tests. The only suitable data set for this set of genes is
NEJM176 and we therefore defined a new classifier bNC2, which coincides with
bNC, except for the data that is used for centroid construction, because bNC2’s
centroids are obtained from NEJM176 instead of Transbig. We conduct a similar
analysis as before for three of the four feature selection methods (the adaptive
Lasso for Cox’s model had to be disregarded due to numerical problems). This
time, we did not split the already small learning set NEJM176 into two parts
for training and validation, but used 5-fold cross-validation instead.
For this analysis bNC2’s performance is considerably higher than bNC’s
in the previous one with only 231 genes as a base set.17 This is particularly
pronounced for the AdaBoost feature selection method, which showed the best
cross-validation performance with sensitivity 89% and specificity 86%. This re-
sult looks very promising especially since we can see a whole interval for feature
set sizes between 70 and 170 elements, that show similar performance. However,
we would like to point out, that in this analysis we could not test the adaptive
Lasso for Cox’s model, which turned out to be the best method in the previous
analysis and might therefore outperform AdaBoost even for the second test set-
ting. Furthermore, the cross-validation results might be a bit over-optimistic,
since the profiles are constructed on the whole data set and hence the left-out
samples used for validation are always part of the classifier’s centroid. Therefore,
a second independent validation would be needed to confirm the results. Nev-
ertheless, the cross-validation performance for the AdaBoost feature selection is
very impressive and far from our expectations.
17Please note, that a direct comparison of the performance measurements cannot be done,
since cross-validation is a less powerful estimate of the classification accuracy than independent
validation.
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Chapter 6
Conclusion and Future Work
In this study we analyzed classification and feature selection methods for the
prediction of breast cancer tumor outcome on the basis of microarray gene ex-
pression data. More specifically, we considered the problem of predicting the
development of distant metastases within a timespan of 5 years. This problem
is translated to a binary classification problem with two possible outcomes: +1
denoting distant metastasis development and −1 denoting the event of remain-
ing distant metastasis free. In contrast to classical analyses, we considered the
two kinds of classification errors (type I and type II, see section 2.3) separately.
This has been done by restricting ourselves to accept a type I error rate, the
rate of misclassification of patients that develop metastases, of maximal 10%
during classifier training.
The microarray technology oﬀers a fast and eﬃcient way for the extraction
of thousands of gene expressions in parallel [30]. However, since it has only
been available since the 1990s, usually for classification one is confronted with
the problem of having only very little sample data compared to a vast amount
of gene expression data. This can often be the cause for overfitting or reporting
overoptimistic results [50]. We tried to avoid this problem by making use of
various data sets, that in total comprise around 1000 samples. Two data sets
(NEJM176 and Transbig of 176 and 283 samples, respectively) were chosen as
a learning set and a third data set (LNpos of 226 samples) for the comparison
of classification results.
After reviewing some general classification methods, to our belief the most
suitable one for this analysis is the nearest centroid classifier, which has been
used in other studies in the literature [34, 59, 60]. Simple classification meth-
ods like this have been shown to give good empirical results also compared to
more sophisticated ones [29]. Furthermore, it is easy to adapt the constraint
of restricting the type II error to 10% during training. The MammaPrint test
[60] is such a nearest centroid classifier incorporating this constraint. We tested
diﬀerent nearest centroid classifiers, where we observed big diﬀerences in per-
formance and were able to extract the best performing classifier on which we
later tested diﬀerent feature selection methods.
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But first, we focused on the nearest centroid classification method itself based
on a set of 70 genes, which is also used for MammaPrint. We investigated the
influence of three dimensions on the nearest centroid classifier:1
• The data used for centroid construction
• The classification rule applied (based on one or two centroids)
• The similarity measure used
In this analysis it turned out that indeed there are huge diﬀerences in classifi-
cation performance depending on how each of the dimensions is defined. For
example, we showed, that the ‘gap’-classification rule using two centroids is in
general superior to classification on only one centroid. The best performing clas-
sifier (on the learning set ) is defined by ‘Transbig’ centroids, using a ‘gap’-based
classification rule and the Pearson correlation coeﬃcient as similarity measure.
Next, we investigated how diﬀerent feature selection methods influence the
performance of this classifier, which showed that not only the characteristics of
the nearest centroid classifier itself, but also the method of selecting features,
strongly influences classification accuracy. For this analysis we considered two
diﬀerent sets (consisting of 231 and 2577 genes, respectively) as a base sets for
the feature selection. The first one has been chosen since, for the second one,
only one data set of 176 samples was available that contains measurements for
all 2577 genes. Results on the smaller base set of 231 show some, but little
diﬀerences between the tested feature selection methods, and did not improve
the performance on the full set of 231 genes much. For the analysis on the
bigger set, however, we could see huge diﬀerences between the methods and
surprisingly good classification results especially for the AdaBoost algorithm,
which showed to be best for this test set.
On the small feature set of 231 genes we compared four feature selection
methods against each other: The nearest shrunken centroid (NSC) [56], the
AdaBoost algorithm for feature selection [14], the adaptive Lasso [65] and the
adaptive Lasso for Cox’s model [64]. Since we want to evaluate their suitability
for improving classification, the comparison is done via measuring performance
of the nearest centroid classifier determined before on the feature sets selected
by these methods. For the AdaBoost feature selection algorithm, this classifier
can directly be incorporated in the selection procedure. In order to achieve the
same for the other methods and thereby controlling the type II error, we defined
a simple sequential forward selection algorithm (SFS). It determines the optimal
subset of genes (of a list of subsets defined by the feature selection methods) by
choosing the one with optimal validation performance. Thereafter, we compared
the nearest centroid classification on those selected subsets by measuring classi-
fication performance on an independent data set (not used during the learning
procedure).
For the analysis based on the set of 231 genes, it turned out, that the per-
formance of the classification on the 70 genes can be improved by 6 - 22%,
1See chapter 4 for a detailed description.
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but compared to the performance on the whole set of 231 the increase is less.
The classification on the set of features selected by AdaBoost and NSC is even
worse or only equally good, respectively, than classification on the whole set.
The best feature selection method according to this test setting is the adap-
tive Lasso for Cox’s model, that showed 60% validation specificity (and 97%
validation sensitivity).
Another interesting observation is, that the number of overlapping genes
between the feature sets selected by the diﬀerent methods is not very diﬀerent
from the overlap that can be expected by randomly choosing features according
to a hypergeometric distribution. This might hint at the fact, that indeed as
stated in [21], there is no unique set of features that is suitable for disease
classification in this context. On the other hand, considering that also the
diﬀerences between the feature selection methods are only minor, we do not
want to draw any general conclusions since the base set of 231 might be to
small.
Therefore, we wanted to repeat the aforementioned analysis on the larger set
of 2577 genes being used for various cancer tests. Unfortunately, of the three
data sets used before, only one provides measurements for this set of 2577.
Hence, we decided to substitute the training/validation measurement for the
feature subset selection by 5-fold cross-validation, which allows us to work with
one data set only. Since we encountered numerical problems with the LassoCox
algorithm for this huge data input, we only compared the NSC, AdaBoost and
Lasso methods using the enlarged base set of 2577 features. The cross-validation
performances are considerably higher than the validation performances in the
previous analysis. The best feature set (selected by AdaBoost) even achieved
up to 86% specificity (and 89% sensitivity) for cross-validation.
When taking a look at the overlap between the feature sets selected by these
methods, we observed, that there is a large overlap of features selected by Ad-
aBoost and Lasso (56 overlapping features compared to an expected number
of only 7 when drawing randomly from a hypergeometric distribution). Other
overlaps – also to the set of 231 genes and the corresponding features selected
on its basis – are very low. Hence, it seems that AdaBoost and Lasso need
a larger, less preselected set of features they can select from in order to eﬀec-
tively contribute to classification improvement. The big overlap between feature
sets selected by these two methods might hint at their superiority compared to
NSC, in that they truly select for genes with high predictive values (also in con-
junction with other features) and therefore, many of those features are selected
by both methods. The characteristics of these algorithms in contrast to those
of NSC support this idea: while NSC only selects features that diﬀer most in
both outcome groups, Lasso and AdaBoost, evaluate the power of the group of
selected genes and not the single genes.
These hypotheses should of course in a next step (if possible) be validated
by using a second independent data set to confirm the superiority of nearest
centroid classification on the sets of selected features by Lasso and especially
AdaBoost.
An alternative way of measuring classification performance, which could
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be used to support the given results, is to conduct a Kaplan-Meier survival
analysis [31]. This method is based on the proportional hazards or Cox model
(as defined for the adaptive Lasso for Cox’s model). It can be used to determine
the diﬀerences in the probability of developing distant metastases for the two
classification outcome groups. This is particularly interesting from a clinical
point of view, since one can then state that for a positive test outcome the
probability for metastasis development is x times higher than for a negative
outcome. We performed this analysis for the best nearest centroid classifier
defined in chapter 4 on the Raster and LNpos data (results not shown) and
were able to confirm, that indeed the group that has been classified positive
(+1) has a significantly higher risk of developing metastasis than the group
that has been classified negative (-1).
This method also provides the advantage of incorporating continuos survival
data, i.e., we do not need to choose an arbitrary threshold of, e.g., 5 years
that defines the separation of the true outcome classes. This class labeling
reduces precision of the true outcome and can be a source of errors in class
labels [29]. For classification methods, however it is indispensable to define
a finite number of class labels. One possibility of addressing this problem is
considering regression instead of classification [25].
This or other more sophisticated classification or feature selection methods
might in the future be able to even further improve the prediction of distant
metastasis development for breast cancer patients by analyzing gene expression
data. For now, we are quite confident that nearest centroid classification – if the
classifier is defined appropriately – is a well suited tool to address this complex
classification task. We have shown that by combining it with a suitable feature
selection method such as the AdaBoost feature selection it can become even
more powerful.
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Appendix A
Abstract
A.1 Abstract (English)
Cancer and especially breast cancer has become a more and more frequent dis-
ease within the last few years. In the clinical context, tumors are subdivided
into diﬀerent categories to provide a more individual treatment. One important
aspect that is used for this categorization is the development of metastases dis-
tant from the primary tumor. In this thesis, we aim at predicting this outcome
by classifying the tumor’s gene expression data. This data is obtained from mi-
croarrays, which is a technology providing a fast and eﬃcient way of extracting
gene expressions, thereby enabling such classification.
The binary classification problem studied here is to decide whether a tumor
will develop distant metastases or not. In contrast to classical studies in this
field, we are not interested in maximizing overall classification performance, but
focus on keeping the type II error (misclassification of metastases developing
patients) low and only in the second place minimize the type I error.
We define diﬀerent nearest centroid classifiers, where the centroids are given
by gene expression profiles consisting of average gene expression values for each
outcome group. We then compare their performance and analyze the influence
of feature selection methods on classification accuracy.
We show that the performance of nearest centroid classification varies a lot
depending on the specific definition of the classifier. Furthermore, we demon-
strate that the feature set, on which the classification is based, has a big influ-
ence on the classifier’s accuracy and choosing an appropriate feature selection
method can therefore lead to a huge improvement in performance. The best
classification result can be observed when combining a specific nearest centroid
classifier with an AdaBoost feature selection algorithm: 5-fold cross-validation
showed 89% sensitivity and 86% specificity.
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A.2 Abstract (German)
Krebs und besonders Brustkrebs ist in den letzten Jahre zu einer mehr und
mehr verbreitete Krankheit geworden. Im klinischen Kontext werden Tumore
in verschieden Kategorien unterteilt, um eine individuellere Behandlung zu er-
möglichen. Ein wichtiger Aspekt zur Bestimmung dieser Kategorien ist die
Entwicklung von Metastasen, die sich (weit) entfernt vom Primärtumor bilden.
Das Ziel dieser Arbeit ist die Vorhersage dieses Krankheitsbildes durch Klas-
sifikation der Genexpressionsdaten des Tumors. Die dafür benötigten Daten
werden mit Hilfe von Mikroarrays gewonnen, einer Technologie die es erlaubt
Genexpressionsdaten schnell und eﬃziente zu extrahiert und dadurch eine solche
Klassifikation ermöglicht.
Wir untersuchen hier das binäre Klassifikationsproblem der Bestimmung ob
ein Tumor entfernte Metastasen bilden wird oder nicht. Im Gegensatz zu klas-
sischen Studien in diesem Bereich wollen wir nicht die globale Klassifikationsgüte
maximieren, sondern versuchen den Fehler zweiter Art (Fehlklassifikation eines
Metastasen entwickelnden Patienten) niedrig zu halten und erst an zweiter Stelle
den Fehler erster Art zu minimieren.
Wir definieren verschiedene nearest centroid Klassifikatoren, wobei die cen-
troids so genannte "Genexpressionsprofile" sind, die aus den durchschnittlichen
Genexpressionswerten von Patient jedes Krankheitsbildes bestehen. Danach
vergleichen wir die Klassifikationsgüte dieser Klassifikatoren und analysieren,
welchen Einfluss Featureselektionsmethoden darauf haben.
Es wir gezeigt, dass die Güte der nearest centroid Klassifikation stark von
der genauen Definition des Klassifikatores abhängt. Des weiteren zeigen wir,
dass die Featuremenge, auf welcher die Klassifikation basiert, einen großen
Einfluss auf die Genauigkeit des Klassifikators hat und durch die Wahl einer
geeigneten Featureselektionsmethode daher desssen Güte erheblich verbessert
werden kann. Das beste Klassifikationsergebnis wird erreicht durch die Kombi-
nation eines bestimmten nearest centroid Klassifikatores mit einem AdaBoost-
Featureselektionsalgorithmus: Eine 5-fache Kreuzvalidierung erreicht 89% Sen-
sitivität (sensitivity) und 89% Spezifität (specificity).
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Appendix B
Definition of Statistical
Measures
Definition 8 (Pearson correlation)
The Pearson correlation coeﬃcient or correlation coeﬃcient of two random vari-
ables X and Y is given by
corr(X,Y ) =
E(X − µX) · E(Y − µY )
σXσY
and
corr(x, y) =
￿
(xi − x¯)(yi − y¯)￿￿
(xi − x¯)2
￿￿
(yi − y¯)2
for the sample correlation coeﬃcient respectively.
Definition 9 (cosine correlation)
The cosine correlation coeﬃcient of two vectors x, y ∈ R is defined as the cosine
of the ankle α enclosed by the vectors:
cosinecorrelation(x, y) = cos(α) =
x · y
||x||||y|| .
Definition 10 (Spearman correlation)
The Spearman correlation coeﬃcient or Spearman rank correlation coeﬃcient
of two sample vectors x and y is given by
r(x, y) = 1− 6
￿
di
2
n(n2 − 1)
where di is the diﬀerence of the statistical ranks of xi and yi and n is the number
of samples in the data set.
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Definition 11 (Kendall correlation)
The Kendall correlation coeﬃcient or Kendall τ coeﬃcient of two sample vectors
x and y is given by
τ(x, y) = 2
nc − nd
n(n− 1)
where nc and nd is the number of concurdant and discordant pairs resp., i.e.,
pairs {xi, yi} and {xj , yj} that fullfill
sgn(xj − xi) = sgn(yj − yi)
and
sgn(xj − xi) = −sgn(yj − yi)
respectively and n is the total number of samples in the data set.
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Appendix C
Data Sets
Data set Size 70 genes 231 genes Full genome Microarray
Nature 78 X X X Hu25K
NEJM 295 X X X Hu25K
NEJM260 260 X X X HD44k
Transbig 324 X X LD8pack
LNpos 241 X X LD8pack
Raster 427 X X (100) LD8pack/44K(100)
Table C.1: Available data sets
Data set Size Selected samples Positive samples Negative samples
Nature 78 78 44 34
NEJM176 199 176 38 138
Transbig 324 283 48 235
LNpos 241 226 32 194
Raster 427 0 - -
Table C.2: Samples selected form the data sets that are used for classification
and the amount of low risk (negative) and high risk (positive) samples thereof.
Only those samples have been used that had a follow-up time of at least five
years with respect to distance metastasis development (otherwise class labels
cannot be defined). For the Nature data set, we used all samples that had been
selected previously in [60] by a slightly diﬀerent approach. This data set is in-
cluded in the NEJM data set and NEJM260 comprises samples of NEJM that
are reanalyzed on the 44k microarray. For classification NEJM260 is subdivided
into two data sets: the samples that coincide with those from Nature (61 sam-
ples) and those that do not (199 samples, where 176 with suﬃcient follow-up
form the set NEJM176).
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Appendix D
Supplementary Information
on Classification Results
Figure D.1: Training and 5-fold cross-validation performance (on NEJM176)
of the nearest centroid classifier bNC2 depending on the number of features
selected by the nearest shrunken centroid feature selection algorithm. The set
with optimal cross-validation performance contains 32 features.
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Figure D.2: Training and 5-fold cross-validation performance (on NEJM176)
of the nearest centroid classifier bNC2 depending on the number of features
selected by the AdaBoost feature selection algorithm. The set with optimal
cross-validation performance contains 134 features.
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Optimal training Parameter on NEJM Optimal training Parameter on Transbig
LR HR LRHR LR HR LRHR
n cosine 0,5922 -0,0544 0,4501 n cosine 0,4225 0,0825 0,3001
n Pearson 0,5336 -0,0683 0,3748 n Pearson 0,4322 0,0658 0,4267
n Spearman 0,5112 0,0658 0,4004 n Spearman 0,3832 0,0838 0,2994
n Kendall 0,3723 0,0476 0,2849 n Kendall 0,2779 0,0559 0,2220
t cosine 0,4475 -0,0622 0,2732 t cosine 0,5216 0,1506 0,2189
t Pearson 0,4717 -0,0350 0,2086 t Pearson 0,5330 0,1476 0,2718
t Spearman 0,4812 -0,1077 0,3501 t Spearman 0,5125 0,1794 0,2899
t Kendall 0,3549 -0,0758 0,2228 t Kendall 0,3640 0,1204 0,2063
Sensitivity on Transbig validation data Sensitivity on NEJM176 validation data
LR HR LRHR LR HR LRHR
n cosine 0,9792 0,9388 0,9167 n cosine 0,8158 0,8421 0,8421
n Pearson 0,9583 0,9583 0,8958 n Pearson 0,8421 0,8684 0,9211
n Spearman 0,9375 0,9375 0,9167 n Spearman 0,8421 0,8684 0,8684
n Kendall 0,9375 0,9375 0,9375 n Kendall 0,8684 0,8421 0,8684
t cosine 0,6458 0,9792 0,9167 t cosine 0,9474 0,6316 0,7895
t Pearson 0,6458 0,9792 0,8750 t Pearson 0,9474 0,6842 0,9474
t Spearman 0,8125 1,0000 0,9583 t Spearman 0,9211 0,5263 0,8947
t Kendall 0,8750 1,0000 0,9583 t Kendall 0,9474 0,5526 0,8947
Specificity on Transbig Validation data Specificity on NEJM176 validation data
LR HR gap LR HR gap
n cosine 0,1787 0,3149 0,3787 n cosine 0,5942 0,4638 0,5507
n Pearson 0,2340 0,2936 0,4128 n Pearson 0,4928 0,4203 0,4203
n Spearman 0,2894 0,3915 0,3532 n Spearman 0,5290 0,4130 0,4420
n Kendall 0,2723 0,3830 0,3532 n Kendall 0,4855 0,4058 0,4420
t cosine 0,3447 0,2681 0,4979 t cosine 0,0507 0,6377 0,5725
t Pearson 0,3106 0,2213 0,5234 t Pearson 0,0652 0,5797 0,4638
t Spearman 0,4000 0,0383 0,3362 t Spearman 0,1014 0,6087 0,4638
t Kendall 0,3617 0,0383 0,3957 t Kendall 0,1159 0,6087 0,4348
Sensitivity of LOOCV on Transbig Sensitivity of LOOCV on NEJM176
LR HR gap LR HR gap
n cosine 0,8958 0,8958 0,8958 n cosine 0,8947 0,8947 0,8947
n Pearson 0,8958 0,8958 0,8958 n Pearson 0,8947 0,8947 0,8947
n Spearman 0,8958 0,8958 0,8958 n Spearman 0,8947 0,8947 0,8947
n Kendall 0,8958 0,8958 0,8958 n Kendall 0,8947 0,8947 0,8947
t cosine 0,8958 0,8958 0,8958 t cosine 0,8947 0,8947 0,8947
t Pearson 0,8958 0,8958 0,8958 t Pearson 0,8947 0,8947 0,8947
t Spearman 0,8958 0,8958 0,8958 t Spearman 0,8947 0,8947 0,8947
t Kendall 0,8958 0,8958 0,8958 t Kendall 0,8947 0,8947 0,8947
Specificity of LOOCV on Transbig Specificity of LOOCV on NEJM176
LR HR gap LR HR gap
n cosine 0,4128 0,4766 0,4468 n cosine 0,3696 0,3551 0,4638
n Pearson 0,3957 0,4340 0,3745 n Pearson 0,3406 0,2826 0,4348
n Spearman 0,4340 0,4128 0,4298 n Spearman 0,3551 0,3913 0,4130
n Kendall 0,4255 0,3915 0,4170 n Kendall 0,3261 0,3913 0,4130
t cosine 0,1617 0,4766 0,5404 t cosine 0,1159 0,4130 0,5290
t Pearson 0,1574 0,4340 0,4723 t Pearson 0,1087 0,3623 0,5145
t Spearman 0,3064 0,3915 0,4383 t Spearman 0,1377 0,2754 0,3768
t Kendall 0,3362 0,3872 0,4298 t Kendall 0,1159 0,2754 0,4275
Figure D.3: Results of the comparison of nearest centroid classifiers trained,
validated and leave-one-out cross-validated on Transbig and NEJM176. In the
first row, for LR and HR the parameter tested is threshold, whereas for LRHR it
is gap. Optimal CV parameters coincide with the optimal training parameters.
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Publications 
  
T. von Landesberger, M. Görner, R. Rehner and T. Schreck. A System for Interactive Visual 
Analysis of Large Graphs Using Motifs in Graph Editing and Aggregation. Proceedings of 
the 14th International Fall Workshop on Vision, Modeling, and Visualization (VMV), 2009. 
T. von Landesberger, M. Görner and T. Schreck. Visual Analysis of Graphs with Multiple 
Connected Components. Proceedings of the IEEE Symposium on Visual Analytics Science 
and Technology (VAST), 2009. 
 
 
 
 
 
 
Working experience 
  
10/2009 – today Bioinformatician (Internship followed by a regular position since 
04/2010) at Agendia BV (Amsterdam, the Netherlands) in the research 
and development department 
• Adjusting and implementing (in Matlab) various classification and 
feature selection methods for the classification of breast cancer 
tumors based on gene expression data 
• Developing and applying a framework for the comparison of 
these methods 
• Interpreting and presenting of results in reports, talks and my 
masterʼs thesis 
02/2008 – 09/2008 Scientific assistant (part-time) at Fraunhofer Institute for Computer 
Graphics (IGD) (Darmstadt, Germany) in the research department A3: 
ʻRealtime Solutions for Simulation and Visual Analyticsʼ 
• Assisted a project team developing a software tool for graph 
visualization and graph analysis 
• Extended this tool by adding features for searching and 
visualizing ʻnetwork-motifsʼ 
• Developed and implemented a new graph visualization tool for 
results obtained by a ʻSelf-Organizing-Mapʼ (SOM) algorithm  
 
 
 
Social commitment 
  
02/2009 – 09/2009 Cooperation at IAESTE Austria (Technischen Universität Wien, 
Austria) 
• Assisted IAESTEʼs internship placement service for international 
students at local companies 
• Supported the interns prior to and during their stay in Austria  
• Developed a marketing strategy for the ʻFirmenmesseʼ career fair 
2009 
10/2007 & 
10/2005 
Tutoring (Technische Universität Darmstadt, Germany) of 
international students during orientation activities 
 
 
 
Programming skills 
  
Java Very good programming skills 
Matlab Very good programming skills  
OpenGL  Good command (embedded in Java) 
 
 
Language proficiency 
  
German Native speaker 
Spanish Fluency 
English Fluency 
Latin ʻLatinumʼ proficiency certificate 
French Working knowledge 
Dutch Basic knowledge 
 
Melanie Görner Universität Wien 
 Doktor Karl Lueger Ring 1 
Geburtsdatum: 23. November 1984 1010 Wien, Österreich 
Nationalität: Deutsch Telefon: +43 (0)1 42770  
 
 
 
 
 
 
Ausbildung 
  
10/2008 – heute Masterstudium Mathematik (Universität Wien, Österreich) im 
Schwerpunkt Biomathematik 
• Abschlussarbeit: „Tumor Classification Based on Gene 
Expression Profiles“ 
• Abschluss voraussichtlich Juli 2010 (aktuelle Durchschnittsnote: 
sehr gut) 
10/2004 – 06/2008 Bachelorstudium „Mathematics with Computer Science” 
(Technische Universität Darmstadt, Deutschland)  
• Auslandsstudium im Studienjahr 2006/2007 (Universidad de 
Granada, Spanien) 
• Abschlussarbeit: „Effizientes Generieren von Zufallsgraphen mit 
vorgegebener Gradsequenz ü̈ber Markov-Ketten“ 
• Abschlussnote: sehr gut 
03/2004 Allgemeinen Hochschulreife (Gymnasium Kirn, Deutschland) 
Abschlussnote: 1,6 (sehr gut) 
 
 
 
Publikationen 
  
T. von Landesberger, M. Görner, R. Rehner and T. Schreck. A System for Interactive Visual 
Analysis of Large Graphs Using Motifs in Graph Editing and Aggregation. Proceedings of 
the 14th International Fall Workshop on Vision, Modeling, and Visualization (VMV), 2009. 
T. von Landesberger, M. Görner and T. Schreck. Visual Analysis of Graphs with Multiple 
Connected Components. Proceedings of the IEEE Symposium on Visual Analytics Science 
and Technology (VAST), 2009. 
 
 
 
 
 
 
Berufserfahrung 
  
10/2009 – heute Bioinformatician (Praktikum, danach Festanstellung seit 04/2010) 
bei Agendia BV (Amsterdam, Niederlande) im Bereich Forschung und 
Entwicklung 
• Anpassung und Implementierung (in Matlab) verschiedener 
Klassifikations- und Feature Selektions-Methoden auf Basis von 
Microarray Genexpressionsdaten für die Klassifizierung von 
Brustkrebs Tumoren 
• Erstellung und Anwendung eines Frameworks zum Vergleich der 
Methoden 
• Interpretation und Präsentation der Ergebnisse in Berichten, 
Vorträgen und in der darauf aufbauenden Masterarbeit 
02/2008 – 09/2008 Wissenschaftliche Hilfskraft am Fraunhofer Institute für 
Graphische Datenverarbeitung (IGD) (Darmstadt, Deutschland) in der 
Arbeitsgruppe A3: „Echtzeitlösungen für Simulation und Visual Analytics“ 
• Mitarbeit in einem Projektteam zur Entwicklung eines Software 
Tools zur Graphvisualisierung und Graphanalyse 
• Erweiterung des Tools durch Features zur Suche und 
Visualisierung von Graphmotiven 
• Entwicklung und Implementierung eines neuen 
Graphvisualisierungstools für Ergebnisse eines „Self-Organizing-
Map“ (SOM) Algorithmus 
 
 
 
Soziales Engagement 
  
02/2009 – 09/2009 Mitarbeit bei IAESTE Austria (Technischen Universität Wien, 
Österreich) 
• Vermittlung von internationalen Praktikanten an lokale 
Unternehmen  
• Betreuung der Praktikanten vor und während ihres Aufenthaltes 
in Österreich 
• Ausarbeitung des Marketingplans für die „Firmenmesse“ 2009 
10/2007 & 
10/2005 
Tutorentätigkeit (Technische Universität Darmstadt, Deutschland) 
für internationale Studenten während Orientierungsveranstaltungen 
 
 
 
Programmierkenntnisse 
  
Java Sehr gute Kenntnisse  
Matlab Sehr gute Kenntnisse  
OpenGL  Kenntnisse als Einbettung in Java 
 
Sprachkenntnisse 
  
Deutsch Muttersprache 
Spanisch Fließend 
Englisch Fließend 
Latein Latinum 
Französisch Erweiterte Grundkenntnisse 
Niederländisch Grundkenntnisse 
 
 
 
Amsterdam, April 2010 
